Almaden Minerals (AAUAF) 20-F 26 Apr 24 2023 FY Annual report (foreign) Financial data

Cover

Cover	12 Months Ended
	Dec. 31, 2023 shares
Entity Addresses [Line Items]
Document Type	20-F
Amendment Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-32702
Entity Registrant Name	ALMADEN MINERALS LTD.
Entity Central Index Key	0001015647
Entity Incorporation, State or Country Code	A1
Entity Address, Address Line One	1333 Johnston Street
Entity Address, Address Line Two	#210
Entity Address, City or Town	Vancouver
Entity Address, State or Province	BC
Entity Address, Country	CA
Entity Address, Postal Zip Code	V6H 3R9
Title of 12(b) Security	Common shares without Par Value
Trading Symbol	AAUAF
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Document Accounting Standard	International Financial Reporting Standards
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	137,221,408
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Name	DAVIDSON & COMPANY LLP
Auditor Location	Vancouver, Canada
Auditor Firm ID	731
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	1333 Johnston Street
Entity Address, Address Line Two	#210
Entity Address, City or Town	Vancouver
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V6H 3R9
Contact Personnel Name	Korm Trieu
Contact Personnel Email Address	ktrieu@almadenminerals.com

Consolidated statements of fina

Consolidated statements of financial position	Dec. 31, 2023 CAD ($)	Dec. 31, 2022 CAD ($)
Current assets
Cash and cash equivalents (Note 13)	$ 4,245,983	$ 6,658,076
Gold in trust (Note 8)	1,082,801	974,397
Accounts receivable and prepaid expenses (Note 4)	453,640	259,471
Total current assets	5,782,424	7,891,944
Non-current assets
Right-of-use assets (Note 5)	330,597	432,319
Property, plant and equipment (Note 6)	6,601,742	6,610,871
Exploration and evaluation assets (Note 7)	1	63,115,076
Total non current assets	6,932,340	70,158,266
TOTAL ASSETS	12,714,764	78,050,210
Current liabilities
Trade and other payables (Note 11 (a))	851,158	340,509
Current portion of lease liabilities (Note 5)	100,531	88,295
Total current liabilities	951,689	428,804
Non-current liabilities
Long-term portion of lease liabilities (Note 5)	277,104	377,635
Gold loan payable (Note 8)	4,371,546	3,929,015
Warrant liability (Note 9)		102,787
Derivative financial liabilities (Note 8)	108,830	306,084
Deferred income tax liability (Note 14)		3,090,208
Total non current liabilities	4,757,480	7,805,729
Total liabilities	5,709,169	8,234,533
EQUITY
Share capital (Note 10)	141,040,654	141,040,654
Reserves (Note 10)	23,356,523	22,546,373
Deficit	(157,391,582)	(93,771,350)
Total equity	7,005,595	69,815,677
TOTAL EQUITY AND LIABILITIES	$ 12,714,764	$ 78,050,210

Consolidated statements of comp

Consolidated statements of comprehensive loss - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Expenses
Professional fees (Note 11(a))	$ 1,113,336	$ 864,051	$ 772,887
Salaries and benefits (Note 11(a))	1,811,073	1,923,952	1,876,911
Travel and promotion	50,120	107,869	200,995
Depreciation (Note 6)	11,166	14,424	16,638
Office and other (Note 11(b))	182,457	156,686	218,879
Amortization of right-of-use assets (Note 5)	101,722	106,791	121,479
Occupancy expenses (Note 5)	39,858	42,655	40,542
Interest expense on lease liabilities (Note 5)	39,502	47,379	13,330
Interest, accretion and standby fees on gold loan payable (Note 8)	540,709	468,308	394,371
Listing and filing fees	193,490	154,505	187,169
Insurance	103,491	96,068	89,476
Directors’ fees (Note 11(a))	140,000	145,000	102,500
Share-based payments (Note 10(d) and 11(a))	810,150	1,478,100	1,870,800
Total Expenses	5,137,074	5,605,788	5,905,977
Other income (loss)
Administrative services fees (Note 11(b))	1,422,347	1,376,428	1,382,344
Interest and other income	370,741	253,869	490,245
Impairment of property, plant and equipment (Note 6)		(7,441,293)
Impairment of exploration and evaluation assets (Note 7)	(63,823,478)
Unrealized gain (loss) on derivative financial liabilities (Note 8)	191,732	110,177	(18,156)
Unrealized gain (loss) on gold in trust (Note 8)	132,895	(6,518)	(35,775)
Unrealized foreign exchange gain (loss) on gold loan payable (Note 8)	103,700	(257,803)	11,535
Unrealized foreign exchange gain (loss) on gold in trust (Note 8)	(24,491)	64,920	(4,011)
Unrealized gain on warrant liability (Note 9)	102,787	520,503	1,747,884
Gain on debt forgiveness (Note 11(a))		177,200
Foreign exchange gain (loss)	(49,599)	302,930	(22,202)
Total other income (loss)	(61,573,366)	(4,899,587)	3,551,864
Loss before income taxes	(66,710,440)	(10,505,375)	(2,354,113)
Deferred income tax recovery (expense) (Note 14)	3,090,208	(1,341,185)	(314,141)
Net loss for the year	(63,620,232)	(11,846,560)	(2,668,254)
Total comprehensive loss for the year	$ (63,620,232)	$ (11,846,560)	$ (2,668,254)
Basic net loss per share	$ (0.46)	$ (0.09)	$ (0.02)
Diluted net loss per share	$ (0.46)	$ (0.09)	$ (0.02)

Consolidated statements of cash

Consolidated statements of cash flows	12 Months Ended
	Dec. 31, 2023 CAD ($)	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 CAD ($)
Operating activities
Net loss for the year	$ (63,620,232)	$ (11,846,560)	$ (2,668,254)
Items not affecting cash
Deferred income tax (recovery) expense	(3,090,208)	1,341,185	314,141
Depreciation	11,166	14,424	16,638
Amortization of right-of-use assets	101,722	106,791	121,479
Impairment of property, plant and equipment		7,441,293
Impairment of exploration and evaluation assets	63,823,478
Interest expenses on lease liability	39,502	47,379	13,330
Interest, accretion and standby fees on gold loan payable	540,709	468,308	394,371
Unrealized (gain) loss on derivative financial liabilities	(191,732)	(110,177)	18,156
Unrealized (gain) loss on gold in trust	(132,895)	6,518	35,775
Unrealized foreign exchange (gain) loss on gold loan payable	(103,700)	257,803	(11,535)
Unrealized foreign exchange (gain) loss on gold in trust	24,491	(64,920)	4,011
Unrealized gain on warrant liability	(102,787)	(520,503)	(1,747,884)
Share-based payments	810,150	1,478,100	1,870,800
Changes in non-cash working capital components
Accounts receivable and prepaid expenses	(194,169)	(103,833)	19,370
Trade and other payables	601,499	(169,206)	19,352
Net cash used in operating activities	(1,483,006)	(1,653,398)	(1,600,250)
Investing activities
Property, plant and equipment – purchase	(2,037)	(47,056)	(10,505)
Exploration and evaluation assets – costs	(799,253)	(1,681,790)	(2,784,645)
Net cash used in investing activities	(801,290)	(1,728,846)	(2,795,150)
Financing activities
Issuance of shares, net of share issue costs			11,610,581
Options exercised			564,750
Repayment of lease liabilities	(127,797)	(130,056)	(144,253)
Net cash from (used in) financing activities	(127,797)	(130,056)	12,031,078
Change in cash and cash equivalents	(2,412,093)	(3,512,300)	7,635,678
Cash and cash equivalents, beginning of year	6,658,076	10,170,376	2,534,698
Cash and cash equivalents, end of year	$ 4,245,983	$ 6,658,076	$ 10,170,376

Consolidated statements of chan

Consolidated statements of changes in equity - CAD ($)	Issued capital [member]	Reserve of share-based payments [member]	Warrants [member]	Total Reserves [Member]	Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 131,189,978	$ 18,528,024	$ 715,968	$ 19,243,992	$ (79,256,536)	$ 71,177,434
Beginning balance, shares at Dec. 31, 2020	120,650,254
IfrsStatementLineItems [Line Items]
Share-based payments		1,870,800		1,870,800		1,870,800
Private placements, net of share issue costs	$ 11,610,581					11,610,581
Private placements, net of share issue costs, shares	15,846,154
Warrant liability	$ (2,371,174)					(2,371,174)
Finders’ warrants issued pursuant to private placement	(130,731)	130,731		130,731
Shares issued for cash on exercise of stock options	$ 564,750					564,750
Shares issued for cash on exercise of stock options, shares	725,000
Fair value of cash stock options transferred to share capital	$ 177,250	(177,250)		(177,250)
Total comprehensive loss for the year					(2,668,254)	(2,668,254)
Ending balance, value at Dec. 31, 2021	$ 141,040,654	20,352,305	715,968	21,068,273	(81,924,790)	80,184,137
Ending balance, shares at Dec. 31, 2021	137,221,408
IfrsStatementLineItems [Line Items]
Share-based payments		1,478,100		1,478,100		1,478,100
Total comprehensive loss for the year					(11,846,560)	(11,846,560)
Ending balance, value at Dec. 31, 2022	$ 141,040,654	21,830,405	715,968	22,546,373	(93,771,350)	69,815,677
Ending balance, shares at Dec. 31, 2022	137,221,408
IfrsStatementLineItems [Line Items]
Share-based payments		810,150		810,150		810,150
Total comprehensive loss for the year					(63,620,232)	(63,620,232)
Ending balance, value at Dec. 31, 2023	$ 141,040,654	$ 22,640,555	$ 715,968	$ 23,356,523	$ (157,391,582)	$ 7,005,595
Ending balance, shares at Dec. 31, 2023	137,221,408

Nature of operations

Nature of operations	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Nature of operations	1. Nature of operations Almaden Minerals Ltd. (the “Company” or “Almaden”) was formed by amalgamation under the laws of the Province of British Columbia, Canada on February 1, 2002. The Company is an advanced exploration stage public company that is engaged directly in the exploration and development of exploration and evaluation property in Mexico. The Company’s shares are trade on the TSX Exchange under the symbol “AMM”. The address of the Company’s registered office is Suite 1710 –1177 West Hastings Street, Vancouver, BC, Canada V6E 2L3. The Company is in the business of exploring and developing mineral projects and its principal asset is the Ixtaca precious metals project located on its Tuligtic claim in Mexico. The Company has not yet determined whether this project has economically recoverable mineral reserves. The recoverability of amounts shown for mineral properties is dependent upon the establishment of a sufficient quantity of economically recoverable reserves, the ability of the Company to obtain the necessary financing or participation of joint venture partners to complete development of the properties, and upon future profitable production or proceeds from the disposition of exploration and evaluation assets. These consolidated financial statements were prepared on a “going concern” basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As of December 31, 2023, the Company had a working capital surplus of $ 4,830,735 7,463,140 63,620,232 11,846,560 1,483,006 1,653,398 157,391,582 93,771,350

Basis of presentation

Basis of presentation	12 Months Ended
	Dec. 31, 2023
Basis Of Presentation
Basis of presentation	2. Basis of presentation (a) Statement of Compliance with International Financial Reporting Standards (“IFRS”) These consolidated financial statements have been prepared in accordance and compliance with IFRS Accounting standards as issued by the International Accounting Standards Board (“IASB”). (b) Basis of preparation These consolidated financial statements have been prepared on a historical cost basis except for the revaluation of certain financial assets and financial liabilities at fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information. These consolidated financial statements, including comparatives, have been prepared on the basis of IFRS standards that are effective as at December 31, 2023. (c) Functional currency The functional and reporting currency of the Company and its subsidiaries is the Canadian dollar. (d) Significant accounting judgments and estimates The preparation of these consolidated financial statements requires management to make judgements and estimates that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these judgements and estimates. The consolidated financial statements include judgements and estimates which, by their nature, are uncertain. The impacts of such judgements and estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects both current and future periods. Significant assumptions about the future and other sources of judgements and estimates that management has made at the statement of financial position dates, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following: Critical Judgments o The analysis of the functional currency for each entity of the Company determined by conducting an analysis of the consideration factors identified in IAS 21, “The Effect of Changes in Foreign Exchange Rates”. In concluding that the Canadian dollar is the functional currency of the parent and its subsidiary companies, management considered the currency that mainly influences the cost of providing goods and services in each jurisdiction in which the Company operates. As no single currency was clearly dominant, the Company also considered secondary indicators including the currency in which funds from financing activities are denominated and the currency in which funds are retained. Going Concern o Management makes an assessment about the Company’s ability to continue as a going concern by taking into the account the consideration of the various factors discussed in Note 1. Judgement is applied by management in determining whether or not the elements giving rise to factors that cause doubt about the ability of the Company to continue as a going concern are present. Estimates o The estimated useful lives of property, plant and equipment which are included in the consolidated statements of financial position and the related depreciation included in profit or loss; o The recoverability of the value of the exploration and evaluation assets which is recorded in the consolidated statements of financial position (Note 3(f)); o The Company uses the Black-Scholes option pricing model to determine the fair value of options, warrants, and derivative financial liabilities in order to calculate share-based payments expense, warrant liability and the fair value of finders’ warrants and stock options. Certain inputs into the model are estimates that involve considerable judgment or could be affected by significant factors that are out of the Company’s control; o The provision for income taxes which is included in profit or loss and the composition of deferred income tax liability included in the consolidated statement of financial position and the evaluation of the recoverability of deferred tax assets based on an assessment of the Company’s ability to utilize the underlying future tax deductions against future taxable income prior to expiry of those deductions; o The assessment of indications of impairment of each exploration and evaluation asset and property plant and equipment and related determination of the net realizable value and write-down of those assets where applicable (Note 3(f)); o The estimated incremental borrowing rate used to calculate the lease liabilities; and o The estimated fair value of gold in trust.

Material accounting policies

Material accounting policies	12 Months Ended
	Dec. 31, 2023
Material Accounting Policies
Material accounting policies	3. Material accounting policies ( a) Basis of consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows: Schedule of consolidated financial statements Jurisdiction Nature of operations Puebla Holdings Inc. Canada Holding company Minera Gorrion, S.A. de C.V. Mexico Exploration company Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements. (b) Foreign currencies Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated. (c) Financial instruments A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost. Financial liabilities comprise the Company’s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest. (i) Impairment of financial assets An ‘expected credit loss’ (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable. (ii) Embedded derivatives Derivatives may be embedded in other financial instruments (the “host instrument”). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss. The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments. Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred. (d) Cash and cash equivalents Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days. (e) Property, plant and equipment Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates: Schedule of property, plant and equipment Furniture, fixtures and other 20 Computer hardware and software 30 Geological library 20 Field equipment 20 Mill equipment Straight line over mine life (11 years) (f) Exploration and evaluation assets The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment. The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment: (i) the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed; (ii) substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned; (iii) exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and (iv) sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale. An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred. The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition. The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount. Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment. All capitalized exploration and evaluation expenditures are monitored for indications of impairment. Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned. (g) Impairment of property, plant and equipment Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs. An asset’s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized. (h) Income taxes Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income. Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. (i) Share-based payments The Company’s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee . Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received. (j) Share capital Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants. Certain of the Company’s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital. (k) Reclamation and closure cost obligations Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made. The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate. Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably. When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee. (l) Net loss per share The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12). (m) Leases At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices. As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability. A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of: · fixed payments, including in-substance fixed payments, less any lease incentives receivable; · variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date; · amounts expected to be payable under a residual value guarantee; · exercise prices of purchase options if the Company is reasonably certain to exercise that option; and · payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss. The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term. (n) Standards issued or amended but not yet effective The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company’s accounting policies or financial statements. IAS 1 –Presentation of Financial Statements (“IAS 1”) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company’s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company’s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.

Accounts receivable and prepaid

Accounts receivable and prepaid expenses	12 Months Ended
	Dec. 31, 2023
Accounts Receivable And Prepaid Expenses
Accounts receivable and prepaid expenses	4. Accounts receivable and prepaid expenses Accounts receivable and prepaid expenses consist of the following: Schedule of accounts receivable and prepaid expenses December 31, December 31, 2023 2022 Accounts receivable (Note 11(b)) $ 389,895 $ 198,942 Prepaid expenses 63,745 60,529 Total $ 453,640 $ 259,471 At December 31, 2023, the Company has recorded value added taxes of $ 164,189 251,775

Right-of-use assets and lease l

Right-of-use assets and lease liabilities	12 Months Ended
	Dec. 31, 2023
Right-of-use Assets And Lease Liabilities
Right-of-use assets and lease liabilities	5. Right-of-use assets and lease liabilities The Company has lease agreements for its headquarter office space in Vancouver, B.C. One lease containing an extension option exercisable only by the Company was exercised on November 22, 2021. The lease was therefore extended from March 31, 2022 to March 31, 2027. The Company reassessed this significant event as a lease modification and has estimated that the potential future lease payments under the extended lease term would result in an increase in lease liability by $ 508,799 The continuity of lease liabilities for the years ended December 31, 2023 and 2022 are as follows: Schedule of continuity of lease liabilities December 31, December 31, Opening balance $ 465,930 $ 548,607 Less: lease payments (127,797 ) (130,056 ) Interest expense 39,502 47,379 377,635 465,930 Less: current portion of lease liabilities (100,531 ) (88,295 ) Long-term portion of lease liabilities $ 277,104 $ 377,635 The Company entered into a sublease arrangement with a third party to lease an office unit from May 1, 2021 to March 31, 2022 under the same terms of the Company’s lease. The Company remains beholden to the obligations set out in its lease dated October 31, 2018. The rental income during the year ended December 31, 2023 (2022 - $ 8,508 22,452 0 The continuity of ROU assets for the years ended December 31, 2023 and 2022 are as follows: Schedule of continuity of ROU assets December 31, December 31, Opening balance $ 432,319 $ 539,110 Less: amortization of ROU assets (101,722 ) (106,791 ) $ 330,597 $ 432,319 During the year ended December 31, 2023, the Company recognized occupancy expenses of $ 39,858 42,655 40,542 As at December 31, 2023, the remaining payments for the operating lease are due as follows: Schedule of remaining payments for the operating lease 2024 2025 2026 2027 2028 Total Office lease $ 170,672 $ 173,970 $ 177,268 $ 44,523 - $ 566,433

Property, plant and equipment

Property, plant and equipment	12 Months Ended
	Dec. 31, 2023
Property Plant And Equipment
Property, plant and equipment	6. Property, plant and equipment Schedule of property, plant and equipment Furniture Computer Computer Geological Field Mill Total $ $ $ $ $ $ $ Cost December 31, 2022 159,171 271,540 198,981 51,760 245,647 6,568,841 7,495,940 Additions 1,770 267 - - - - 2,037 Impairment of property, plant and equipment - - - - - - - December 31, 2023 160,941 271,807 198,981 51,760 245,647 6,568,841 7,497,977 Accumulated depreciation December 31, 2022 153,203 251,441 192,138 50,975 237,312 - 885,069 Depreciation 1,223 6,066 2,053 157 1,667 - 11,166 December 31, 2023 154,426 257,507 194,191 51,132 238,979 - 896,235 Carrying amounts December 31, 2022 5,968 20,099 6,843 785 8,335 6,568,841 6,610,871 December 31, 2023 6,515 14,300 4,790 628 6,668 6,568,841 6,601,742 Furniture Computer Computer Geological Field Mill Total $ $ $ $ $ $ $ Cost December 31, 2021 158,219 267,004 198,981 51,760 245,647 13,968,566 14,890,177 Additions 952 4,536 - - - 41,568 47,056 Impairment of property, plant and equipment - - - - - (7,441,293 ) (7,441,293 ) December 31, 2022 159,171 271,540 198,981 51,760 245,647 6,568,841 7,495,940 Accumulated depreciation December 31, 2021 151,390 244,043 189,206 50,779 235,227 - 870,645 Depreciation 1,813 7,398 2,932 196 2,085 - 14,424 December 31, 2022 153,203 251,441 192,138 50,975 237,312 - 885,069 Carrying amounts December 31, 2021 6,829 22,961 9,775 981 10,420 13,968,566 14,019,532 December 31, 2022 5,968 20,099 6,843 785 8,335 6,568,841 6,610,871 As at December 31, 2022, the Company recorded an impairment of $ 7,441,293

Exploration and evaluation asse

Exploration and evaluation assets	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Exploration and evaluation assets	7. Exploration and evaluation assets Schedule of exploration and evaluation assets Tuligtic Other Property Total Exploration and evaluation assets $ $ $ Acquisition costs: Opening balance - (December 31, 2022) 11,308,721 - 11,308,721 Additions - - - Deductions - - - Impairment of acquisition costs (11,308,720 ) - (11,308,720 ) Closing balance - (December 31, 2023) 1 - 1 Deferred exploration costs: Opening balance - (December 31, 2022) 51,806,355 - 51,806,355 Costs incurred during the year Professional/technical fees 159,031 - 159,031 Geochemical, metallurgy 1,022 - 1,022 Travel and accommodation 70,324 - 70,324 Geology, geophysics and exploration 172,455 - 172,455 Supplies and miscellaneous 318,047 - 318,047 Environmental and permit 384,421 - 384,421 Value-added tax (Note 4) 164,189 164,189 Refund - Value-added tax (561,086 ) - (561,086 ) Impairment of deferred exploration cost (52,514,758 ) - (52,514,758 ) Total deferred exploration costs during the year (51,806,355 ) - (51,806,355 ) Closing balance - (December 31, 2023) - - - Total exploration and evaluation assets 1 - 1 During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $ 11,308,720 0 52,514,758 0 Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims. Tuligtic Other Property Total Exploration and evaluation assets $ $ $ Acquisition costs: Opening balance - (December 31, 2021) 11,211,756 1 11,211,757 Additions 96,965 - 96,965 Deductions - (1 ) (1 ) Closing balance - (December 31, 2022) 11,308,721 - 11,308,721 Deferred exploration costs: Opening balance - (December 31, 2021) 50,219,882 - 50,219,882 Costs incurred during the year Professional/technical fees 143,075 - 143,075 Claim maintenance/lease costs 169,651 - 169,651 Geochemical, metallurgy 3,929 - 3,929 Travel and accommodation 155,195 - 155,195 Geology, geophysics and exploration 307,712 - 307,712 Supplies and miscellaneous 310,804 - 310,804 Environmental and permit 640,541 - 640,541 Value-added tax (Note 4) 251,775 251,775 Refund - Value-added tax (396,209 ) - (396,209 ) Total deferred exploration costs during the year 1,586,473 - 1,586,473 Closing balance - (December 31, 2022) 51,806,355 - 51,806,355 Total exploration and evaluation assets 63,115,076 - 63,115,076 The following is a description of the Company’s most significant property interests: (a) Tuligtic The Tuligtic property consisted of two mineral concessions which the Company applied for in 2002 and 2008. The mineral concessions were granted in 2003 and 2009, respectively (“the “Concessions”). The Company held a 100% interest in the Concessions subject to a 2.0% NSR royalty held by Almadex Minerals Ltd (‘’Almadex”). The Concessions covered approximately 14,000 Ha, including certain endowed lands of the Ejido Tecoltemi, which comprise approximately 330 Ha. The Concessions are located in Puebla, Mexico and underpinned the discovery made by the Company in 2010, referred to as “Ixtaca”. In 2015, the Ejido Tecoltemi initiated a lawsuit against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office) asserting that the Mexican mining law is unconstitutional because it fails to include provisions requiring consultation of indigenous communities before granting mineral titles. This lawsuit ultimately came before Mexico’s Supreme Court (“SCJN”), and in early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that the Ministry of Economy (“Economia”) should have provided for a consultation procedure with relevant indigenous communities prior to issuing the Concessions to the Company. The SCJN ordered Economia to declare the Concessions ineffective - to revert them to application status - and to conduct indigenous consultation prior to re-issuing them. In July, 2022 the Company announced that Economia notified Almaden that the Concessions were “ineffective”. The Company understood that the mineral title had reverted to application status, and that these applications preserved the mineral rights for Almaden but did not allow the Company to engage in exploration, until such time as Economia completed its court-ordered process to properly issue the Concessions after conducting indigenous consultation in the area covered by the mineral title applications. However, on February 22, 2023, Economia made a submission to Mexican courts seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”). The Submission claimed that the applications contain technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the Concessions in 2003 and 2009. This Submission has been reviewed by the Mexican district and appeals courts, which have ruled that the Submission complies with the SCJN ruling. However, the appeals court’s ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”), which the Company has done. The TFJA has granted a definitive injunction to Almaden’s Mexican subsidiary, Minera Gorrión (“MG”), which prevents Economia from releasing the mineral rights covered by the Company’s mineral title applications to third parties while the TFJA trial regarding the substance and legality of the Submission continues. In summary, the rights held by Almaden to the Ixtaca project are now based on two mineral title applications which have been denied by Economia, through its issuance of the Submission. The Company is in the process of disputing this denial through the Mexican Federal Administrative Court. (b) Other Property On May 26, 2022, the Company transferred the 40 1 (c) Other Expenditures incurred by the Company in Mexico are subject to Mexican Value added tax (“VAT”). The VAT is included in exploration and evaluation assets as incurred. Under Mexican law, VAT paid can be used in the future to offset amounts resulting from VAT charged on sales. Under certain circumstances and subject to approval from tax authorities, A Company can also apply for an early refund of VAT prior to generating sales. During 2023, the Company received a VAT recovery of $ 561,086 396,209 506,394 173,876 139,313 446,184

Gold loan payable and gold in t

Gold loan payable and gold in trust	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Gold loan payable and gold in trust	8. Gold loan payable and gold in trust The Company has entered into a secured gold loan agreement (“Gold Loan”) with Almadex or the “Lender” pursuant to which Almadex has agreed to loan up to 1,597 2,072,060 2,790,858 Under the terms of the Gold Loan, the Company will be entitled to draw-down the gold in minimum 400 ounce tranches. At any given time, the amount of gold ounces drawn multiplied by the London Bullion Market Association (“LBMA”) AM gold price in US dollars, plus any accrued interest or unpaid fees, shall constitute the Loan Value. The maturity date for the Gold Loan is March 31, 2024, and can be extended by two years 2 100 The interest rate of the Gold Loan is 10 1 In addition, the Company has issued Almadex 500,000 1.50 50,000 5 1.54 0 44.25 Security for the loan is certain equipment related to the Rock Creek Mill, which is not required for the Ixtaca Project. The Gold Loan includes industry standard provisions in the event of default, material breach and change of control. The Gold Loan was recorded at fair value at inception and is subsequently measured at amortized cost using the effective interest method, recognizing interest expense on an effective yield basis. The Company has determined that the Gold Loan contains multiple derivatives which are embedded in the US dollar denominated debt instrument. As the convertible Gold Loan is denominated in US dollars and is convertible into common shares based upon a variable Canadian dollar conversion rate, the fixed for fixed criteria is not met. As such, the conversion option cannot be classified as an equity instrument and is deemed to have no value. The embedded derivative from indexation of the loan principal portion to the movement in the price of gold is classified as a derivate financial liability and is marked to market at each period end using the Black-Scholes option-pricing model. At inception, the following assumptions were used: expected life of five 5 1.57 11.06 191,732 110,177 0.25 4.00 9.93 1.25 4.00 11.57 The continuity of gold loan payable and derivative financial liabilities are as follows: Schedule of gold loan payable December 31, December 31, Gold loan payable – opening balance $ 3,929,015 $ 3,227,545 Accrued interest expense 353,372 314,024 Accrued standby fees 10,377 9,416 Accretion expense 176,960 144,868 Foreign exchange difference (98,178 ) 233,162 Gold loan payable $ 4,371,546 $ 3,929,015 Derivative financial liabilities – opening balance $ 306,084 $ 391,620 Change in fair value through profit & loss (191,732 ) (110,177 ) Foreign exchange difference (5,522 ) 24,641 Derivative financial liabilities $ 108,830 $ 306,084 As at December 31, 2023, Almaden has 397 397 1,082,801 974,397 The continuity of gold in trust are as follows: Schedule of gold in trust December 31, 2023 December 31, 2022 Ounces $ Ounces $ Gold in trust, opening balance 397 974,397 397 915,995 Sale of gold in trust - - - - Gain on sale - - - - Change in fair value through profit & loss - 132,895 - (6,518 ) Foreign exchange difference 0 (24,491 ) 0 64,920 397 1,082,801 397 974,397

Warrant liability

Warrant liability	12 Months Ended
	Dec. 31, 2023
Warrant Liability
Warrant liability	9. Warrant liability In connection with the registered direct offering private placement completed during the year ended December 31, 2021, the Company issued a total of 7,923,077 0.80 2,371,174 Schedule of warrant assumptions Risk-free interest rate 0.53 Expected life of warrants 3.00 Expected annualized volatility 72.42 Dividend Nil Forfeiture rate 0 The fair value is recorded as a derivative financial liability as these warrants are exercisable in US dollars, differing from the Company’s functional currency. The change in fair value resulted in an unrealized gain of $ 102,787 520,503 Schedule of derivative financial liability December 31, 2023 December 31, 2022 Risk-free interest rate 3.91 % 3.99 % Expected life of warrants 0.21 1.21 Expected annualized volatility 36.25 % 69.83 % Dividend Nil Nil Forfeiture rate 0 % 0 %

Share capital and reserves

Share capital and reserves	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Share capital and reserves	10. Share capital and reserves (a) Authorized share capital At December 31, 2023, the authorized share capital comprised an unlimited number of common shares. The common shares do not have a par value. All issued shares are fully paid. (b) Details of private placements and other issues of common shares in 2023, 2022 and 2021 On March 18, 2021, the Company closed a registered direct offering private placement for the purchase and sale of 15,846,154 common shares and common share warrants to purchase up to 7,923,077 common shares at a combined purchase price of US$0.65 per unit for aggregate gross proceeds of US$10.3 million (CAD$12,838,950). The common share warrants will be immediately exercisable, have an exercise price of US$0.80 per share and will expire three years from the date of issuance. Share issue costs included a finder’s fee of $834,532 in cash, and finders’ warrants to purchase up to 435,769 common shares at a price of US$0.80 per common share until March 18, 2024. The fair value of the finders’ warrants was $130,731. In connection with the registered direct offering, the Company also incurred $393,837 in share issue costs. These amounts were recorded as a reduction to share capital. The proceeds of the registered direct offering were allocated $10,467,776 to share capital and $2,371,174 to warrants. Share issue costs of $40,990 was recorded for fees paid related to the Short Form Base Shelf Prospectus filed on February 25, 2021. (c) Warrants The continuity of warrants for the years ended December 31, 2023, 2022 and 2021 are as follows: Schedule of Continuity of Warrants Exercise December 31, December 31, Expiry date price 2022 Issued Exercised Expired 2023 March 27, 2023 $ 0.50 5,489,658 - - (5,489,658 ) - August 6, 2023 $ 0.90 3,100,000 - - (3,100,000 ) - March 18, 2024 USD$ 0.80 7,923,077 - - - 7,923,077 March 18, 2024 USD$ 0.80 435,769 - - - 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 17,448,504 - - (8,589,658 ) 8,858,846 Weighted average exercise price $ 0.88 - - $ 0.64 $ 1.08 The weighted average remaining life of warrants outstanding at December 31, 2023 was 0.22 0.80 Exercise December 31, December 31, Expiry date price 2021 Issued Exercised Expired 2022 June 7, 2022 $ 1.35 4,720,000 - - (4,720,000 ) - March 27, 2023 $ 0.50 5,489,658 - - - 5,489,658 August 6, 2023 $ 0.90 3,100,000 - - - 3,100,000 March 18, 2024 USD$ 0.80 7,923,077 - - - 7,923,077 March 18, 2024 USD$ 0.80 435,769 - - - 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 22,168,504 - - (4,720,000 ) 17,448,504 Weighted average exercise price $ 0.95 - - $ 1.35 $ 0.88 The weighted average remaining life of warrants outstanding at December 31, 2022 was 0.80 1.51 Exercise December 31, December 31, Expiry date price 2020 Issued Exercised Expired 2021 June 7, 2022 $ 1.35 4,720,000 - - - 4,720,000 March 27, 2023 $ 0.50 5,489,658 - - - 5,489,658 August 6, 2023 $ 0.90 3,100,000 - - - 3,100,000 March 18, 2024 USD$ 0.80 - 7,923,077 - - 7,923,077 March 18, 2024 USD$ 0.80 - 435,769 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 13,809,658 8,358,846 - - 22,168,504 Weighted average exercise price $ 0.92 $ 1.00 - - $ 0.95 The weighted average remaining life of warrants outstanding at December 31, 2021 was 1.51 2.08 The weighted average fair value of finders’ warrants granted during the years ended December 31, 2023, 2022 and 2021 calculated using the Black-Scholes option-pricing model at the issue dates, are as follows: Weighted average assumptions used Schedule of -Warrant Fair Value Assumptions Number of Date of issue Fair value Risk free Expected life (in years) Expected Expected 435,769 March 18, 2021 $ 0.30 0.53 3 72.42 $Nil (d) Share purchase option compensation plan The Company’s stock option plan permits the issuance of options up to a maximum of 10 2 1,217,141 The maximum term of all options is five years. The Board of Directors determines the term of the option (to a maximum of five years) and the time during which any option may vest. Options granted to consultants or persons providing investor relations services shall vest in stages with no more than 25 The Company’s stock option plan permits the option holder to exercise cashless by surrendering a portion of the underlying option shares to pay for the exercise price and the corresponding withholding taxes, if applicable. The continuity of stock options for the years ended December 31, 2023, 2022 and 2021 are as follows: Schedule of Share options Expiry date Exercise December 31, Granted Exercised Expired December 31, February 9, 2023 $ 0.97 350,000 - - (350,000 ) - March 3, 2023 $ 0.96 250,000 - - (250,000 ) - March 31, 2023 $ 0.68 1,975,000 - - (1,975,000 ) - May 8, 2023 $ 0.69 100,000 - - (100,000 ) - May 28, 2023 $ 0.65 100,000 - - (100,000 ) - July 8, 2023 $ 0.62 2,420,000 - - (2,420,000 ) - September 18, 2023 $ 0.51 960,000 - - (960,000 ) - March 7, 2027 $ 0.38 1,125,000 - - - 1,125,000 June 10, 2027 $ 0.33 3,640,000 - - - 3,640,000 October 4, 2027 $ 0.30 755,000 - - - 755,000 December 16, 2027 $ 0.33 855,000 - - - 855,000 February 14, 2028 $ 0.30 - 600,000 - - 600,000 April 3, 2028 $ 0.26 - 1,975,000 - - 1,975,000 July 10, 2028 $ 0.16 - 2,520,000 - - 2,520,000 September 19, 2028 $ 0.18 - 1,035,000 - - 1,035,000 Options outstanding and exercisable 12,530,000 6,130,000 - (6,155,000 ) 12,505,000 Weighted average exercise price $ 0.49 $ 0.21 - $ 0.66 $ 0.27 The weighted average remaining life of stock options outstanding at December 31, 2023 was 3.96 2.53 Expiry date Exercise December 31, Granted Exercised Expired December 31, March 4, 2022 $ 0.47 1,125,000 - - (1,125,000 ) - April 30, 2022 $ 0.41 100,000 - - (100,000 ) - April 30, 2022 $ 0.58 220,000 - - (220,000 ) - May 31, 2022 $ 0.62 600,000 - - (600,000 ) - June 9, 2022 $ 0.64 1,980,000 - - (1,980,000 ) - October 3, 2022 $ 1.13 860,000 - - (860,000 ) - December 15, 2022 $ 0.89 900,000 - - (900,000 ) - February 9, 2023 $ 0.97 350,000 - - - 350,000 March 3, 2023 $ 0.96 250,000 - - - 250,000 March 31, 2023 $ 0.68 1,975,000 - - - 1,975,000 May 8, 2023 $ 0.69 100,000 - - - 100,000 May 28, 2023 $ 0.65 100,000 - - - 100,000 July 8, 2023 $ 0.62 2,470,000 - - (50,000 ) 2,420,000 September 18, 2023 $ 0.51 960,000 - - - 960,000 March 7, 2027 $ 0.38 - 1,125,000 - - 1,125,000 June 10, 2027 $ 0.33 - 3,640,000 - - 3,640,000 October 4, 2027 $ 0.30 - 755,000 - - 755,000 December 16, 2027 $ 0.33 - 855,000 - - 855,000 Options outstanding and exercisable 11,990,000 6,375,000 - (5,835,000 ) 12,530,000 Weighted average exercise price $ 0.68 $ 0.34 - $ 0.71 $ 0.49 The weighted average remaining life of stock options outstanding at December 31, 2022 was 2.53 0.98 Expiry date Exercise December 31, Granted Exercised Expired December 31, February 7, 2021 $ 1.11 300,000 - - (300,000 ) - February 7, 2021 $ 0.84 425,000 - (375,000 ) (50,000 ) - March 29, 2021 $ 1.08 400,000 - - (400,000 ) - March 29, 2021 $ 0.90 100,000 - - (100,000 ) - May 6, 2021 $ 0.69 557,000 - (275,000 ) (282,000 ) - July 7, 2021 $ 0.80 1,612,000 - (75,000 ) (1,537,000 ) - August 13, 2021 $ 1.01 150,000 - - (150,000 ) - September 16, 2021 $ 0.90 1,155,000 - - (1,155,000 ) - December 12, 2021 $ 1.00 200,000 - - (200,000 ) - March 4, 2022 $ 0.47 1,125,000 - - - 1,125,000 April 30, 2022 $ 0.41 100,000 - - - 100,000 April 30, 2022 $ 0.58 220,000 - - - 220,000 May 31, 2022 $ 0.62 700,000 - - (100,000 ) 600,000 June 9, 2022 $ 0.64 2,180,000 - - (200,000 ) 1,980,000 October 3, 2022 $ 1.13 1,346,000 - - (486,000 ) 860,000 December 15, 2022 $ 0.89 972,000 - - (72,000 ) 900,000 February 9, 2023 $ 0.97 - 450,000 - (100,000 ) 350,000 March 3, 2023 $ 0.96 - 325,000 - (75,000 ) 250,000 March 31, 2023 $ 0.68 - 1,975,000 - - 1,975,000 May 8, 2023 $ 0.69 - 100,000 - - 100,000 May 28, 2023 $ 0.65 - 100,000 - - 100,000 July 8, 2023 $ 0.62 - 2,470,000 - - 2,470,000 September 18, 2023 $ 0.51 - 960,000 - - 960,000 Options outstanding and exercisable 11,542,000 6,380,000 (725,000 ) (5,207,000 ) 11,990,000 Weighted average exercise price $ 0.80 $ 0.67 $ 0.78 $ 0.90 $ 0.68 The weighted average remaining life of stock options outstanding at December 31, 2021 was 0.98 1.08 The fair value of options granted during the years ended December 31, 2023, 2022 and 2021, calculated using the Black-Scholes option-pricing model at grant date, are as follows: Schedule of share option fair value assumptions Number Date of grant Fair value Risk free Expected Expected Expected 1,035,000 September 19, 2023 $ 0.10 3.96 % 5 71.15 % $Nil 2,520,000 July 10, 2023 $ 0.12 3.81 % 5 70.98 % $Nil 1,975,000 April 3, 2023 $ 0.15 2.87 % 5 68.52 % $Nil 600,000 February 13, 2023 $ 0.18 3.43 % 5 68.61 % $Nil 855,000 December 16, 2022 $ 0.19 3.07 % 5 66.04 % $Nil 755,000 October 4, 2022 $ 0.22 3.42 % 5 82.02 % $Nil 3,640,000 June 10, 2022 $ 0.22 3.38 % 5 82.61 % $Nil 1,125,000 March 7, 2022 $ 0.31 1.65 % 5 85.37 % $Nil 960,000 September 17, 2021 $ 0.23 0.45 % 2 82.96 % $Nil 2,470,000 July 8, 2021 $ 0.25 0.45 % 2 84.98 % $Nil 100,000 May 28, 2021 $ 0.30 0.32 % 2 86.03 % $Nil 100,000 May 7, 2021 $ 0.30 0.33 % 2 86.33 % $Nil 1,975,000 March 31, 2021 $ 0.31 0.22 % 2 85.85 % $Nil 325,000 March 2, 2021 $ 0.43 0.26 % 2 85.48 % $Nil 450,000 February 9, 2021 $ 0.49 0.19 % 2 84.04 % $Nil Total share-based payments expenses as a result of options granted and vested during the year ended December 31, 2023 was $ 810,150 1,478,100 1,870,800

Related party transactions and

Related party transactions and balances	12 Months Ended
	Dec. 31, 2023
Related Party Transactions And Balances
Related party transactions and balances	11. Related party transactions and balances (a) Compensation of key management personnel Key management includes members of the Board, the Chair, the President and Chief Executive Officer, the Chief Financial Officer, the Executive Vice President, and the Vice President, Project Development. The net aggregate compensation paid or payable to key management for services after recovery from Azucar Minerals Ltd. (Azucar) and Almadex (Note 11 (b)) is as follows: Schedule of related party payments December 31, December 31, December 31, 2023 2022 2021 Professional fees $ 50,588 $ 60,000 $ 60,000 Salaries and benefits 398,307 (3) 484,435 (2) 450,522 (1) Share-based payments 702,000 1,212,300 1,551,850 Directors’ fees 140,000 145,000 102,500 Total $ 1,290,895 $ 1,901,735 $ 2,164,872 (1) As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022. (2) As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables. (3) As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables. (b) Administrative Services Agreements The Company recovers a portion of rent, office and license expenses from Azucar pursuant to an Administrative Services Agreement dated May 15, 2015 and First Amending Agreement dated December 16, 2015 between the Company and Azucar. The Company also recovers a portion of expenses from Almadex pursuant to an Administrative Services Agreement dated March 29, 2018 between the Company and Almadex. During the year ended December 31, 2023, the Company received $ 75,853 185,068 412,812 1,346,494 1,191,360 969,532 At December 31, 2023, included in accounts receivable is $ 7,005 64,006 369,045 117,044 Under the Administrative Services Agreements, the Company is the sole and exclusive manager of Azucar and Almadex that provides general management services, office space, executive personnel, human resources, geological technical support, accounting and financial services at cost with no mark-up or additional direct charge. The three companies are considered related parties though common officers. (c) Other related party transactions At December 31, 2023, the Company accrued $Nil 0 80,727 During the year ended December 31, 2023, the Company employed the Chair’s daughter for a salary of $ 45,300 48,800 41,300

Net loss per share

Net loss per share	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Net loss per share	12. Net loss per share Basic and diluted net loss per share The calculation of basic net loss per share for the year ended December 31, 2023 was based on the loss attributable to common shareholders of $ 63,620,232 11,846,560 2,668,254 137,221,408 137,221,408 133,842,894 The calculation of diluted net loss per share for the year ended December 31, 2023, 2022 and 2021 did not include the effect of stock options and warrants, as they were considered to be anti-dilutive.

Supplemental cash flow informat

Supplemental cash flow information	12 Months Ended
	Dec. 31, 2023
Supplemental Cash Flow Information
Supplemental cash flow information	13. Supplemental cash flow information Supplemental information regarding non-cash transactions is as follows: Schedule of supplemental information Investing and financing activities December 31, December 31, December 31, Exploration and evaluation assets expenditures included in trade and other payables - $ 90,850 $ 89,203 Right-of-use assets - - (508,799 ) Warrant liability - - 2,371,174 Fair value of finders’ warrants - - 130,731 Lease liabilities - - 508,799 Fair value of cash stock options transferred to share capital on exercise of options - - 177,250 Supplemental information regarding the split between cash and cash equivalents is as follows: Schedule of supplemental information of cash and cash equivalents December 31, December 31, Cash $ 1,658,863 $ 1,542,956 Term Deposits 2,587,120 5,115,120 Total cash and cash equivalents $ 4,245,983 $ 6,658,076

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Taxes
Income Taxes	14. Income Taxes (a) The provision for income taxes differs from the amounts computed by applying the Canadian statutory rates to the net loss before income taxes due to the following: Schedule of deferred income taxes December 31, December 31, December 31, Loss before income taxes $ (66,710,410 ) $ (10,505,375 ) $ (2,354,113 ) Statutory rate 27.00 % 27.00 % 27.00 % Expected income tax (18,011,811 ) (2,836,451 ) (635,611 ) Effect of different tax rates in foreign jurisdictions (2,005,959 ) (83,891 ) 5,281 Non-deductible share-based payments 218,741 399,087 505,116 Other permanent items 2,484,720 1,838,169 (620,413 ) Change in deferred tax assets not recognized 15,403,428 2,471,723 733,447 Share issuance costs - - (331,660 ) True-ups and other (1,179,327 ) (447,452 ) 657,981 Deferred income tax (recovery) expense $ (3,090,208 ) $ 1,341,185 $ 314,141 (b) The Company’s deferred income tax liability relates to the Mexican income tax and Special Mining Duty (“SMD”) associated with the Tuligtic project. The significant components of deferred income tax assets (liabilities) are as follows: Schedule of deferred tax assets and liabilities December 31, December 31, Deferred tax assets Non-capital losses $ - $ 2,477,570 Exploration and evaluation assets 1,434,880 - 1,434,880 2,477,570 Deferred tax liabilities Exploration and evaluation assets (1,434,880 ) (5,567,778 ) Net deferred tax liabilities $ - $ (3,090,208 ) (c) Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following: Schedule of deductible temporary differences December 31, December 31, Non-capital loss carry forwards $ 32,616,394 $ 25,487,951 Capital loss carry forwards 23,360,422 24,538,993 Exploration and evaluation assets 39,102,815 8,188,922 Share issue costs 551,134 858,548 Property, plant and equipment 7,748,032 7,782,024 Donations 32,960 32,960 Investment tax credit 223,873 223,873 $ 103,635,630 $ 67,113,271 At December 31, 2023, the Company had operating loss carry forwards available for tax purposes in Canada of $ 27,592,166 25,487,951 4,588,699 0

Financial instruments

Financial instruments	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Financial instruments	15. Financial instruments The fair values of the Company’s cash and cash equivalents, accounts receivable and trade and other payables approximate their carrying values because of the short-term nature of these instruments. Except for warrant liability and derivative financial liabilities, the Company does not carry any financial instruments at FVTPL. The Company is exposed to certain financial risks, including currency risk, credit risk, liquidity risk, interest rate risk and commodity and equity price risk. (a) Currency risk The Company’s property interests in Mexico make it subject to foreign currency fluctuations and inflationary pressures which may adversely affect the Company’s financial position, results of operations and cash flows. The Company is affected by changes in exchange rates between the Canadian dollar, the US dollar and the Mexican peso. The Company does not invest in foreign currency contracts to mitigate the risks. As at December 31, 2023, the Company is exposed to foreign exchange risk through the following monetary assets and liabilities denominated in currencies other than the functional currency of the applicable subsidiary: Schedule of assets and liabilities All amounts in Canadian dollars US dollar Mexican peso Cash and cash equivalents $ 2,343,681 $ 458,149 Accounts receivable and prepaid expenses 4,703 113 Gold in trust 1,082,801 - Total assets $ 3,431,185 $ 458,262 Trade and other payables $ 53,348 $ 14,087 Gold loan payable 4,371,546 - Derivative financial liabilities 108,830 - Total liabilities $ 4,533,724 $ 14,087 Net assets $ (1,102,539 ) $ 444,175 A 10% change in the US dollar exchange rate relative to the Canadian dollar would change the Company’s net loss by $ 110,000 A 10% change in the Mexican peso relative to the Canadian dollar would change the Company’s net loss by $ 44,000 (b) Credit risk The Company’s cash and cash equivalents are held in large financial institutions, located in both Canada and Mexico. Cash equivalents mature at less than ninety days during the twelve months following the statement of financial position date. The Company’s accounts receivable consist of amounts due from related parties which are subsequently collected. To mitigate exposure to credit risk on cash and cash equivalents, the Company has established policies to limit the concentration of credit risk with any given banking institution where the funds are held, to ensure counterparties demonstrate minimum acceptable credit risk worthiness and ensure liquidity of available funds. As at December 31, 2023, the Company’s maximum exposure to credit risk is the carrying value of its cash and cash equivalents, and accounts receivable. (c) Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. Liquidity risk is considered low as the Company has sufficient cash and cash equivalent to meet its current liabilities. Trade and other payables are due within twelve months of the statement of financial position date. (d) Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to varying interest rates on cash and cash equivalents. The Company has no debt bearing variable interest rate. A 1% change in the interest rate would change the Company’s net loss by $ 42,000 (e) Commodity and equity price risk The ability of the Company to explore its exploration and evaluation assets and the future profitability of the Company are directly related to the market price of gold and other precious metals. The Company monitors gold prices to determine the appropriate course of action to be taken by the Company. Equity price risk is defined as the potential adverse impact on the Company’s performance due to movements in individual equity prices or general movements in the level of the stock market. A 1% change in the commodity price would change the Company’s net loss by $ 11,000 (f) Classification of financial instruments IFRS 13 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value as follows: Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and Level 3 – inputs for the asset or liability that are not based on observable market data (unobservable inputs). The following table sets forth the Company’s financial assets and liabilities measured at fair value by level within the fair value hierarchy. Schedule of assets and liabilities at fair value Level 1 Level 2 Level 3 Total $ $ $ $ Derivative financial liabilities - 108,830 - 108,830

Management of capital

Management of capital	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Management of capital	16. Management of capital The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk. The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk. The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares and, acquire or dispose of assets. In order to maximize ongoing exploration efforts, the Company does not pay out dividends. The Company’s investment policy is to invest its short-term excess cash in highly liquid short-term interest-bearing investments with short term maturities, selected with regards to the expected timing of expenditures from continuing operations. The Company expects its current capital resources will be sufficient to carry its exploration plans and operations for the foreseeable future. There were no changes to the Company’s approach to the management of capital during the period. The Company has no externally imposed capital requirements.

Segmented information

Segmented information	12 Months Ended
	Dec. 31, 2023
Segmented Information
Segmented information	17. Segmented information The Company operates in one reportable operating segment, being the acquisition and exploration of mineral resource properties. The Company’s non-current assets are located in the following geographic locations: Schedule of non-current Assets December 31, December 31, Canada $ 361,967 $ 472,435 United States 6,568,840 6,568,840 Mexico 1,533 63,116,991 $ 6,932,340 $ 70,158,266

Subsequent event

Subsequent event	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Subsequent event	18. Subsequent event On March 12, 2024, the Company provided notice to Almadex that it is extending the maturity date from March 31, 2024 to March 31, 2026 pursuant to the Gold Loan.

Material accounting policies (P

Material accounting policies (Policies)	12 Months Ended
	Dec. 31, 2023
Material Accounting Policies
Basis of consolidation	( a) Basis of consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows: Schedule of consolidated financial statements Jurisdiction Nature of operations Puebla Holdings Inc. Canada Holding company Minera Gorrion, S.A. de C.V. Mexico Exploration company Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.
Foreign currencies	(b) Foreign currencies Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.
Financial instruments	(c) Financial instruments A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost. Financial liabilities comprise the Company’s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest. (i) Impairment of financial assets An ‘expected credit loss’ (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable. (ii) Embedded derivatives Derivatives may be embedded in other financial instruments (the “host instrument”). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss. The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments. Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.
Cash and cash equivalents	(d) Cash and cash equivalents Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.
Property, plant and equipment	(e) Property, plant and equipment Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates: Schedule of property, plant and equipment Furniture, fixtures and other 20 Computer hardware and software 30 Geological library 20 Field equipment 20 Mill equipment Straight line over mine life (11 years)
Exploration and evaluation assets	(f) Exploration and evaluation assets The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment. The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment: (i) the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed; (ii) substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned; (iii) exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and (iv) sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale. An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred. The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition. The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount. Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment. All capitalized exploration and evaluation expenditures are monitored for indications of impairment. Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.
Impairment of property, plant and equipment	(g) Impairment of property, plant and equipment Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs. An asset’s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.
Income taxes	(h) Income taxes Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income. Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.
Share-based payments	(i) Share-based payments The Company’s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee . Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.
Share capital	(j) Share capital Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants. Certain of the Company’s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.
Reclamation and closure cost obligations	(k) Reclamation and closure cost obligations Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made. The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate. Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably. When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.
Net loss per share	(l) Net loss per share The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).
Leases	(m) Leases At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices. As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability. A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of: · fixed payments, including in-substance fixed payments, less any lease incentives receivable; · variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date; · amounts expected to be payable under a residual value guarantee; · exercise prices of purchase options if the Company is reasonably certain to exercise that option; and · payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss. The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.
Standards issued or amended but not yet effective	(n) Standards issued or amended but not yet effective The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company’s accounting policies or financial statements. IAS 1 –Presentation of Financial Statements (“IAS 1”) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company’s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company’s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.

Material accounting policies (T

Material accounting policies (Tables)	12 Months Ended
	Dec. 31, 2023
Material Accounting Policies
Schedule of consolidated financial statements	Schedule of consolidated financial statements Jurisdiction Nature of operations Puebla Holdings Inc. Canada Holding company Minera Gorrion, S.A. de C.V. Mexico Exploration company
Schedule of property, plant and equipment	Schedule of property, plant and equipment Furniture, fixtures and other 20 Computer hardware and software 30 Geological library 20 Field equipment 20 Mill equipment Straight line over mine life (11 years)

Accounts receivable and prepa_2

Accounts receivable and prepaid expenses (Tables)	12 Months Ended
	Dec. 31, 2023
Accounts Receivable And Prepaid Expenses
Schedule of accounts receivable and prepaid expenses	Schedule of accounts receivable and prepaid expenses December 31, December 31, 2023 2022 Accounts receivable (Note 11(b)) $ 389,895 $ 198,942 Prepaid expenses 63,745 60,529 Total $ 453,640 $ 259,471

Right-of-use assets and lease_2

Right-of-use assets and lease liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Right-of-use Assets And Lease Liabilities
Schedule of continuity of lease liabilities	Schedule of continuity of lease liabilities December 31, December 31, Opening balance $ 465,930 $ 548,607 Less: lease payments (127,797 ) (130,056 ) Interest expense 39,502 47,379 377,635 465,930 Less: current portion of lease liabilities (100,531 ) (88,295 ) Long-term portion of lease liabilities $ 277,104 $ 377,635
Schedule of continuity of ROU assets	Schedule of continuity of ROU assets December 31, December 31, Opening balance $ 432,319 $ 539,110 Less: amortization of ROU assets (101,722 ) (106,791 ) $ 330,597 $ 432,319
Schedule of remaining payments for the operating lease	Schedule of remaining payments for the operating lease 2024 2025 2026 2027 2028 Total Office lease $ 170,672 $ 173,970 $ 177,268 $ 44,523 - $ 566,433

Property, plant and equipment (

Property, plant and equipment (Tables)	12 Months Ended
	Dec. 31, 2023
Property Plant And Equipment
Schedule of property, plant and equipment	Schedule of property, plant and equipment Furniture Computer Computer Geological Field Mill Total $ $ $ $ $ $ $ Cost December 31, 2022 159,171 271,540 198,981 51,760 245,647 6,568,841 7,495,940 Additions 1,770 267 - - - - 2,037 Impairment of property, plant and equipment - - - - - - - December 31, 2023 160,941 271,807 198,981 51,760 245,647 6,568,841 7,497,977 Accumulated depreciation December 31, 2022 153,203 251,441 192,138 50,975 237,312 - 885,069 Depreciation 1,223 6,066 2,053 157 1,667 - 11,166 December 31, 2023 154,426 257,507 194,191 51,132 238,979 - 896,235 Carrying amounts December 31, 2022 5,968 20,099 6,843 785 8,335 6,568,841 6,610,871 December 31, 2023 6,515 14,300 4,790 628 6,668 6,568,841 6,601,742 Furniture Computer Computer Geological Field Mill Total $ $ $ $ $ $ $ Cost December 31, 2021 158,219 267,004 198,981 51,760 245,647 13,968,566 14,890,177 Additions 952 4,536 - - - 41,568 47,056 Impairment of property, plant and equipment - - - - - (7,441,293 ) (7,441,293 ) December 31, 2022 159,171 271,540 198,981 51,760 245,647 6,568,841 7,495,940 Accumulated depreciation December 31, 2021 151,390 244,043 189,206 50,779 235,227 - 870,645 Depreciation 1,813 7,398 2,932 196 2,085 - 14,424 December 31, 2022 153,203 251,441 192,138 50,975 237,312 - 885,069 Carrying amounts December 31, 2021 6,829 22,961 9,775 981 10,420 13,968,566 14,019,532 December 31, 2022 5,968 20,099 6,843 785 8,335 6,568,841 6,610,871

Exploration and evaluation as_2

Exploration and evaluation assets (Tables)	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Schedule of exploration and evaluation assets	Schedule of exploration and evaluation assets Tuligtic Other Property Total Exploration and evaluation assets $ $ $ Acquisition costs: Opening balance - (December 31, 2022) 11,308,721 - 11,308,721 Additions - - - Deductions - - - Impairment of acquisition costs (11,308,720 ) - (11,308,720 ) Closing balance - (December 31, 2023) 1 - 1 Deferred exploration costs: Opening balance - (December 31, 2022) 51,806,355 - 51,806,355 Costs incurred during the year Professional/technical fees 159,031 - 159,031 Geochemical, metallurgy 1,022 - 1,022 Travel and accommodation 70,324 - 70,324 Geology, geophysics and exploration 172,455 - 172,455 Supplies and miscellaneous 318,047 - 318,047 Environmental and permit 384,421 - 384,421 Value-added tax (Note 4) 164,189 164,189 Refund - Value-added tax (561,086 ) - (561,086 ) Impairment of deferred exploration cost (52,514,758 ) - (52,514,758 ) Total deferred exploration costs during the year (51,806,355 ) - (51,806,355 ) Closing balance - (December 31, 2023) - - - Total exploration and evaluation assets 1 - 1 During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $ 11,308,720 0 52,514,758 0 Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims. Tuligtic Other Property Total Exploration and evaluation assets $ $ $ Acquisition costs: Opening balance - (December 31, 2021) 11,211,756 1 11,211,757 Additions 96,965 - 96,965 Deductions - (1 ) (1 ) Closing balance - (December 31, 2022) 11,308,721 - 11,308,721 Deferred exploration costs: Opening balance - (December 31, 2021) 50,219,882 - 50,219,882 Costs incurred during the year Professional/technical fees 143,075 - 143,075 Claim maintenance/lease costs 169,651 - 169,651 Geochemical, metallurgy 3,929 - 3,929 Travel and accommodation 155,195 - 155,195 Geology, geophysics and exploration 307,712 - 307,712 Supplies and miscellaneous 310,804 - 310,804 Environmental and permit 640,541 - 640,541 Value-added tax (Note 4) 251,775 251,775 Refund - Value-added tax (396,209 ) - (396,209 ) Total deferred exploration costs during the year 1,586,473 - 1,586,473 Closing balance - (December 31, 2022) 51,806,355 - 51,806,355 Total exploration and evaluation assets 63,115,076 - 63,115,076

Gold loan payable and gold in_2

Gold loan payable and gold in trust (Tables)	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Schedule of gold loan payable	Schedule of gold loan payable December 31, December 31, Gold loan payable – opening balance $ 3,929,015 $ 3,227,545 Accrued interest expense 353,372 314,024 Accrued standby fees 10,377 9,416 Accretion expense 176,960 144,868 Foreign exchange difference (98,178 ) 233,162 Gold loan payable $ 4,371,546 $ 3,929,015 Derivative financial liabilities – opening balance $ 306,084 $ 391,620 Change in fair value through profit & loss (191,732 ) (110,177 ) Foreign exchange difference (5,522 ) 24,641 Derivative financial liabilities $ 108,830 $ 306,084
Schedule of gold in trust	Schedule of gold in trust December 31, 2023 December 31, 2022 Ounces $ Ounces $ Gold in trust, opening balance 397 974,397 397 915,995 Sale of gold in trust - - - - Gain on sale - - - - Change in fair value through profit & loss - 132,895 - (6,518 ) Foreign exchange difference 0 (24,491 ) 0 64,920 397 1,082,801 397 974,397

Warrant liability (Tables)

Warrant liability (Tables)	12 Months Ended
	Dec. 31, 2023
Warrant Liability
Schedule of warrant assumptions	Schedule of warrant assumptions Risk-free interest rate 0.53 Expected life of warrants 3.00 Expected annualized volatility 72.42 Dividend Nil Forfeiture rate 0
Schedule of derivative financial liability	Schedule of derivative financial liability December 31, 2023 December 31, 2022 Risk-free interest rate 3.91 % 3.99 % Expected life of warrants 0.21 1.21 Expected annualized volatility 36.25 % 69.83 % Dividend Nil Nil Forfeiture rate 0 % 0 %

Share capital and reserves (Tab

Share capital and reserves (Tables)	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Schedule of Continuity of Warrants	Schedule of Continuity of Warrants Exercise December 31, December 31, Expiry date price 2022 Issued Exercised Expired 2023 March 27, 2023 $ 0.50 5,489,658 - - (5,489,658 ) - August 6, 2023 $ 0.90 3,100,000 - - (3,100,000 ) - March 18, 2024 USD$ 0.80 7,923,077 - - - 7,923,077 March 18, 2024 USD$ 0.80 435,769 - - - 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 17,448,504 - - (8,589,658 ) 8,858,846 Weighted average exercise price $ 0.88 - - $ 0.64 $ 1.08 The weighted average remaining life of warrants outstanding at December 31, 2023 was 0.22 0.80 Exercise December 31, December 31, Expiry date price 2021 Issued Exercised Expired 2022 June 7, 2022 $ 1.35 4,720,000 - - (4,720,000 ) - March 27, 2023 $ 0.50 5,489,658 - - - 5,489,658 August 6, 2023 $ 0.90 3,100,000 - - - 3,100,000 March 18, 2024 USD$ 0.80 7,923,077 - - - 7,923,077 March 18, 2024 USD$ 0.80 435,769 - - - 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 22,168,504 - - (4,720,000 ) 17,448,504 Weighted average exercise price $ 0.95 - - $ 1.35 $ 0.88 The weighted average remaining life of warrants outstanding at December 31, 2022 was 0.80 1.51 Exercise December 31, December 31, Expiry date price 2020 Issued Exercised Expired 2021 June 7, 2022 $ 1.35 4,720,000 - - - 4,720,000 March 27, 2023 $ 0.50 5,489,658 - - - 5,489,658 August 6, 2023 $ 0.90 3,100,000 - - - 3,100,000 March 18, 2024 USD$ 0.80 - 7,923,077 - - 7,923,077 March 18, 2024 USD$ 0.80 - 435,769 435,769 May 14, 2024 $ 1.50 500,000 - - - 500,000 Warrants outstanding and exercisable 13,809,658 8,358,846 - - 22,168,504 Weighted average exercise price $ 0.92 $ 1.00 - - $ 0.95 The weighted average remaining life of warrants outstanding at December 31, 2021 was 1.51 2.08
Schedule of -Warrant Fair Value Assumptions	Schedule of -Warrant Fair Value Assumptions Number of Date of issue Fair value Risk free Expected life (in years) Expected Expected 435,769 March 18, 2021 $ 0.30 0.53 3 72.42 $Nil
Schedule of Share options	Schedule of Share options Expiry date Exercise December 31, Granted Exercised Expired December 31, February 9, 2023 $ 0.97 350,000 - - (350,000 ) - March 3, 2023 $ 0.96 250,000 - - (250,000 ) - March 31, 2023 $ 0.68 1,975,000 - - (1,975,000 ) - May 8, 2023 $ 0.69 100,000 - - (100,000 ) - May 28, 2023 $ 0.65 100,000 - - (100,000 ) - July 8, 2023 $ 0.62 2,420,000 - - (2,420,000 ) - September 18, 2023 $ 0.51 960,000 - - (960,000 ) - March 7, 2027 $ 0.38 1,125,000 - - - 1,125,000 June 10, 2027 $ 0.33 3,640,000 - - - 3,640,000 October 4, 2027 $ 0.30 755,000 - - - 755,000 December 16, 2027 $ 0.33 855,000 - - - 855,000 February 14, 2028 $ 0.30 - 600,000 - - 600,000 April 3, 2028 $ 0.26 - 1,975,000 - - 1,975,000 July 10, 2028 $ 0.16 - 2,520,000 - - 2,520,000 September 19, 2028 $ 0.18 - 1,035,000 - - 1,035,000 Options outstanding and exercisable 12,530,000 6,130,000 - (6,155,000 ) 12,505,000 Weighted average exercise price $ 0.49 $ 0.21 - $ 0.66 $ 0.27 The weighted average remaining life of stock options outstanding at December 31, 2023 was 3.96 2.53 Expiry date Exercise December 31, Granted Exercised Expired December 31, March 4, 2022 $ 0.47 1,125,000 - - (1,125,000 ) - April 30, 2022 $ 0.41 100,000 - - (100,000 ) - April 30, 2022 $ 0.58 220,000 - - (220,000 ) - May 31, 2022 $ 0.62 600,000 - - (600,000 ) - June 9, 2022 $ 0.64 1,980,000 - - (1,980,000 ) - October 3, 2022 $ 1.13 860,000 - - (860,000 ) - December 15, 2022 $ 0.89 900,000 - - (900,000 ) - February 9, 2023 $ 0.97 350,000 - - - 350,000 March 3, 2023 $ 0.96 250,000 - - - 250,000 March 31, 2023 $ 0.68 1,975,000 - - - 1,975,000 May 8, 2023 $ 0.69 100,000 - - - 100,000 May 28, 2023 $ 0.65 100,000 - - - 100,000 July 8, 2023 $ 0.62 2,470,000 - - (50,000 ) 2,420,000 September 18, 2023 $ 0.51 960,000 - - - 960,000 March 7, 2027 $ 0.38 - 1,125,000 - - 1,125,000 June 10, 2027 $ 0.33 - 3,640,000 - - 3,640,000 October 4, 2027 $ 0.30 - 755,000 - - 755,000 December 16, 2027 $ 0.33 - 855,000 - - 855,000 Options outstanding and exercisable 11,990,000 6,375,000 - (5,835,000 ) 12,530,000 Weighted average exercise price $ 0.68 $ 0.34 - $ 0.71 $ 0.49 The weighted average remaining life of stock options outstanding at December 31, 2022 was 2.53 0.98 Expiry date Exercise December 31, Granted Exercised Expired December 31, February 7, 2021 $ 1.11 300,000 - - (300,000 ) - February 7, 2021 $ 0.84 425,000 - (375,000 ) (50,000 ) - March 29, 2021 $ 1.08 400,000 - - (400,000 ) - March 29, 2021 $ 0.90 100,000 - - (100,000 ) - May 6, 2021 $ 0.69 557,000 - (275,000 ) (282,000 ) - July 7, 2021 $ 0.80 1,612,000 - (75,000 ) (1,537,000 ) - August 13, 2021 $ 1.01 150,000 - - (150,000 ) - September 16, 2021 $ 0.90 1,155,000 - - (1,155,000 ) - December 12, 2021 $ 1.00 200,000 - - (200,000 ) - March 4, 2022 $ 0.47 1,125,000 - - - 1,125,000 April 30, 2022 $ 0.41 100,000 - - - 100,000 April 30, 2022 $ 0.58 220,000 - - - 220,000 May 31, 2022 $ 0.62 700,000 - - (100,000 ) 600,000 June 9, 2022 $ 0.64 2,180,000 - - (200,000 ) 1,980,000 October 3, 2022 $ 1.13 1,346,000 - - (486,000 ) 860,000 December 15, 2022 $ 0.89 972,000 - - (72,000 ) 900,000 February 9, 2023 $ 0.97 - 450,000 - (100,000 ) 350,000 March 3, 2023 $ 0.96 - 325,000 - (75,000 ) 250,000 March 31, 2023 $ 0.68 - 1,975,000 - - 1,975,000 May 8, 2023 $ 0.69 - 100,000 - - 100,000 May 28, 2023 $ 0.65 - 100,000 - - 100,000 July 8, 2023 $ 0.62 - 2,470,000 - - 2,470,000 September 18, 2023 $ 0.51 - 960,000 - - 960,000 Options outstanding and exercisable 11,542,000 6,380,000 (725,000 ) (5,207,000 ) 11,990,000 Weighted average exercise price $ 0.80 $ 0.67 $ 0.78 $ 0.90 $ 0.68 The weighted average remaining life of stock options outstanding at December 31, 2021 was 0.98 1.08
Schedule of share option fair value assumptions	Schedule of share option fair value assumptions Number Date of grant Fair value Risk free Expected Expected Expected 1,035,000 September 19, 2023 $ 0.10 3.96 % 5 71.15 % $Nil 2,520,000 July 10, 2023 $ 0.12 3.81 % 5 70.98 % $Nil 1,975,000 April 3, 2023 $ 0.15 2.87 % 5 68.52 % $Nil 600,000 February 13, 2023 $ 0.18 3.43 % 5 68.61 % $Nil 855,000 December 16, 2022 $ 0.19 3.07 % 5 66.04 % $Nil 755,000 October 4, 2022 $ 0.22 3.42 % 5 82.02 % $Nil 3,640,000 June 10, 2022 $ 0.22 3.38 % 5 82.61 % $Nil 1,125,000 March 7, 2022 $ 0.31 1.65 % 5 85.37 % $Nil 960,000 September 17, 2021 $ 0.23 0.45 % 2 82.96 % $Nil 2,470,000 July 8, 2021 $ 0.25 0.45 % 2 84.98 % $Nil 100,000 May 28, 2021 $ 0.30 0.32 % 2 86.03 % $Nil 100,000 May 7, 2021 $ 0.30 0.33 % 2 86.33 % $Nil 1,975,000 March 31, 2021 $ 0.31 0.22 % 2 85.85 % $Nil 325,000 March 2, 2021 $ 0.43 0.26 % 2 85.48 % $Nil 450,000 February 9, 2021 $ 0.49 0.19 % 2 84.04 % $Nil

Related party transactions an_2

Related party transactions and balances (Tables)	12 Months Ended
	Dec. 31, 2023
Related Party Transactions And Balances
Schedule of related party payments	Schedule of related party payments December 31, December 31, December 31, 2023 2022 2021 Professional fees $ 50,588 $ 60,000 $ 60,000 Salaries and benefits 398,307 (3) 484,435 (2) 450,522 (1) Share-based payments 702,000 1,212,300 1,551,850 Directors’ fees 140,000 145,000 102,500 Total $ 1,290,895 $ 1,901,735 $ 2,164,872 (1) As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022. (2) As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables. (3) As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.

Supplemental cash flow inform_2

Supplemental cash flow information (Tables)	12 Months Ended
	Dec. 31, 2023
Supplemental Cash Flow Information
Schedule of supplemental information	Schedule of supplemental information Investing and financing activities December 31, December 31, December 31, Exploration and evaluation assets expenditures included in trade and other payables - $ 90,850 $ 89,203 Right-of-use assets - - (508,799 ) Warrant liability - - 2,371,174 Fair value of finders’ warrants - - 130,731 Lease liabilities - - 508,799 Fair value of cash stock options transferred to share capital on exercise of options - - 177,250
Schedule of supplemental information of cash and cash equivalents	Schedule of supplemental information of cash and cash equivalents December 31, December 31, Cash $ 1,658,863 $ 1,542,956 Term Deposits 2,587,120 5,115,120 Total cash and cash equivalents $ 4,245,983 $ 6,658,076

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Taxes
Schedule of deferred income taxes	Schedule of deferred income taxes December 31, December 31, December 31, Loss before income taxes $ (66,710,410 ) $ (10,505,375 ) $ (2,354,113 ) Statutory rate 27.00 % 27.00 % 27.00 % Expected income tax (18,011,811 ) (2,836,451 ) (635,611 ) Effect of different tax rates in foreign jurisdictions (2,005,959 ) (83,891 ) 5,281 Non-deductible share-based payments 218,741 399,087 505,116 Other permanent items 2,484,720 1,838,169 (620,413 ) Change in deferred tax assets not recognized 15,403,428 2,471,723 733,447 Share issuance costs - - (331,660 ) True-ups and other (1,179,327 ) (447,452 ) 657,981 Deferred income tax (recovery) expense $ (3,090,208 ) $ 1,341,185 $ 314,141
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities December 31, December 31, Deferred tax assets Non-capital losses $ - $ 2,477,570 Exploration and evaluation assets 1,434,880 - 1,434,880 2,477,570 Deferred tax liabilities Exploration and evaluation assets (1,434,880 ) (5,567,778 ) Net deferred tax liabilities $ - $ (3,090,208 )
Schedule of deductible temporary differences	Schedule of deductible temporary differences December 31, December 31, Non-capital loss carry forwards $ 32,616,394 $ 25,487,951 Capital loss carry forwards 23,360,422 24,538,993 Exploration and evaluation assets 39,102,815 8,188,922 Share issue costs 551,134 858,548 Property, plant and equipment 7,748,032 7,782,024 Donations 32,960 32,960 Investment tax credit 223,873 223,873 $ 103,635,630 $ 67,113,271

Financial instruments (Tables)

Financial instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Notes and other explanatory information [abstract]
Schedule of assets and liabilities	Schedule of assets and liabilities All amounts in Canadian dollars US dollar Mexican peso Cash and cash equivalents $ 2,343,681 $ 458,149 Accounts receivable and prepaid expenses 4,703 113 Gold in trust 1,082,801 - Total assets $ 3,431,185 $ 458,262 Trade and other payables $ 53,348 $ 14,087 Gold loan payable 4,371,546 - Derivative financial liabilities 108,830 - Total liabilities $ 4,533,724 $ 14,087 Net assets $ (1,102,539 ) $ 444,175
Schedule of assets and liabilities at fair value	Schedule of assets and liabilities at fair value Level 1 Level 2 Level 3 Total $ $ $ $ Derivative financial liabilities - 108,830 - 108,830

Segmented information (Tables)

Segmented information (Tables)	12 Months Ended
	Dec. 31, 2023
Segmented Information
Schedule of non-current Assets	Schedule of non-current Assets December 31, December 31, Canada $ 361,967 $ 472,435 United States 6,568,840 6,568,840 Mexico 1,533 63,116,991 $ 6,932,340 $ 70,158,266

Nature of operations (Details N

Nature of operations (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Notes and other explanatory information [abstract]
Working capital surplus	$ 4,830,735	$ 7,463,140
Net loss	63,620,232	11,846,560	$ 2,668,254
Negative cash flows from operations	1,483,006	1,653,398	$ 1,600,250
Accumulated deficit	$ 157,391,582	$ 93,771,350

Material accounting policies (D

Material accounting policies (Details)	12 Months Ended
	Dec. 31, 2023
Puebla Holdings Inc. [Member]
IfrsStatementLineItems [Line Items]
Entity name	Puebla Holdings Inc.
Jurisdiction	Canada
Nature of operations	Holding company
Minera Gorrion, S.A. de C.V. [Member]
IfrsStatementLineItems [Line Items]
Entity name	Minera Gorrion, S.A. de C.V.
Jurisdiction	Mexico
Nature of operations	Exploration company

Material accounting policies _2

Material accounting policies (Details 1)	12 Months Ended
	Dec. 31, 2023
Furniture, fixtures and fittings [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment	20%
Computer equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment	30%
Geological library [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment	20%
Field equipment [member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment	20%
Mill Equipment [Member]
IfrsStatementLineItems [Line Items]
Property, plant and equipment	Straight line over mine life (11 years)

Accounts receivable and prepa_3

Accounts receivable and prepaid expenses (Details) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
Accounts Receivable And Prepaid Expenses
Accounts receivable (Note 11(b))	$ 389,895	$ 198,942
Prepaid expenses	63,745	60,529
Total	$ 453,640	$ 259,471

Accounts receivable and prepa_4

Accounts receivable and prepaid expenses (Details Narrative) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
Tuligtic Project [Member]
IfrsStatementLineItems [Line Items]
Value added tax receivables	$ 164,189	$ 251,775

Right-of-use assets and lease_3

Right-of-use assets and lease liabilities (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Right-of-use Assets And Lease Liabilities
Opening balance	$ 465,930	$ 548,607
Less: lease payments	(127,797)	(130,056)
Interest expense	39,502	47,379	$ 13,330
Ending balance	377,635	465,930	$ 548,607
Less: current portion of lease liabilities	(100,531)	(88,295)
Long-term portion of lease liabilities	$ 277,104	$ 377,635

Right-of-use assets and lease_4

Right-of-use assets and lease liabilities (Details 1) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Right-of-use Assets And Lease Liabilities
Opening balance	$ 432,319	$ 539,110
Less: amortization of ROU assets	(101,722)	(106,791)	$ (121,479)
Ending balance	$ 330,597	$ 432,319	$ 539,110

Right-of-use assets and lease_5

Right-of-use assets and lease liabilities (Details 2)	Dec. 31, 2023 CAD ($)
IfrsStatementLineItems [Line Items]
Remaining payments for office lease	$ 566,433
Not later than one year [member]
IfrsStatementLineItems [Line Items]
Remaining payments for office lease	170,672
Later than one year and not later than two years [member]
IfrsStatementLineItems [Line Items]
Remaining payments for office lease	173,970
Later than two years and not later than three years [member]
IfrsStatementLineItems [Line Items]
Remaining payments for office lease	177,268
Later than three years and not later than four years [member]
IfrsStatementLineItems [Line Items]
Remaining payments for office lease	44,523
Later than four years and not later than five years [member]
IfrsStatementLineItems [Line Items]
Remaining payments for office lease

Right-of-use assets and lease_6

Right-of-use assets and lease liabilities (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Right-of-use Assets And Lease Liabilities
Increase in lease liability	$ 508,799
Operating sublease income	0	$ 8,508	$ 22,452
Occupancy expense	$ 39,858	$ 42,655	$ 40,542

Property, plant and equipment_2

Property, plant and equipment (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Carrying amounts	$ 6,601,742	$ 6,610,871	$ 14,019,532
Computer software [member]
IfrsStatementLineItems [Line Items]
Carrying amounts	4,790	6,843	9,775
Furniture, fixtures and fittings [member]
IfrsStatementLineItems [Line Items]
Carrying amounts	6,515	5,968	6,829
Computer equipment [member]
IfrsStatementLineItems [Line Items]
Carrying amounts	14,300	20,099	22,961
Geological library [member]
IfrsStatementLineItems [Line Items]
Carrying amounts	628	785	981
Field equipment [member]
IfrsStatementLineItems [Line Items]
Carrying amounts	6,668	8,335	10,420
Mill Equipment [Member]
IfrsStatementLineItems [Line Items]
Carrying amounts	6,568,841	6,568,841	$ 13,968,566
Gross carrying amount [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	7,495,940	14,890,177
Additions/reduction (1)	2,037	47,056
Impairment of property, plant and equipment		(7,441,293)
Balance at ending, cost	7,497,977	7,495,940
Gross carrying amount [member] | Computer software [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	198,981	198,981
Additions/reduction (1)
Impairment of property, plant and equipment
Balance at ending, cost	198,981	198,981
Gross carrying amount [member] | Furniture, fixtures and fittings [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	159,171	158,219
Additions/reduction (1)	1,770	952
Impairment of property, plant and equipment
Balance at ending, cost	160,941	159,171
Gross carrying amount [member] | Computer equipment [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	271,540	267,004
Additions/reduction (1)	267	4,536
Impairment of property, plant and equipment
Balance at ending, cost	271,807	271,540
Gross carrying amount [member] | Geological library [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	51,760	51,760
Additions/reduction (1)
Impairment of property, plant and equipment
Balance at ending, cost	51,760	51,760
Gross carrying amount [member] | Field equipment [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	245,647	245,647
Additions/reduction (1)
Impairment of property, plant and equipment
Balance at ending, cost	245,647	245,647
Gross carrying amount [member] | Mill Equipment [Member]
IfrsStatementLineItems [Line Items]
Balance at beginning, cost	6,568,841	13,968,566
Additions/reduction (1)		41,568
Impairment of property, plant and equipment		(7,441,293)
Balance at ending, cost	6,568,841	6,568,841
Accumulated depreciation, amortisation and impairment [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	885,069	870,645
Depreciation	11,166	14,424
Balance at ending, accumulated depreciation	896,235	885,069
Accumulated depreciation, amortisation and impairment [member] | Computer software [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	192,138	189,206
Depreciation	2,053	2,932
Balance at ending, accumulated depreciation	194,191	192,138
Accumulated depreciation, amortisation and impairment [member] | Furniture, fixtures and fittings [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	153,203	151,390
Depreciation	1,223	1,813
Balance at ending, accumulated depreciation	154,426	153,203
Accumulated depreciation, amortisation and impairment [member] | Computer equipment [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	251,441	244,043
Depreciation	6,066	7,398
Balance at ending, accumulated depreciation	257,507	251,441
Accumulated depreciation, amortisation and impairment [member] | Geological library [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	50,975	50,779
Depreciation	157	196
Balance at ending, accumulated depreciation	51,132	50,975
Accumulated depreciation, amortisation and impairment [member] | Field equipment [member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation	237,312	235,227
Depreciation	1,667	2,085
Balance at ending, accumulated depreciation	238,979	237,312
Accumulated depreciation, amortisation and impairment [member] | Mill Equipment [Member]
IfrsStatementLineItems [Line Items]
Balance at beginning, accumulated depreciation
Depreciation
Balance at ending, accumulated depreciation

Property, plant and equipment_3

Property, plant and equipment (Details Narrative)	12 Months Ended
	Dec. 31, 2022 CAD ($)
Property Plant And Equipment
Impairment on mill equipment	$ 7,441,293

Exploration and evaluation as_3

Exploration and evaluation assets (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Opening balance	$ 11,308,721	$ 11,211,757
Additions		96,965
Deductions		(1)
Impairment of acquisition costs	(11,308,720)
Closing balance	1	11,308,721
Opening balance	51,806,355	50,219,882
Professional/technical fees	159,031	143,075
Claim maintenance/lease costs		169,651
Geochemical, metallurgy	1,022	3,929
Travel and accommodation	70,324	155,195
Geology, geophysics and exploration	172,455	307,712
Supplies and miscellaneous	318,047	310,804
Environmental and permit	384,421	640,541
Value-added tax (Note 4)	164,189	251,775
Refund - Value-added tax	(561,086)	(396,209)
Impairment of deferred exploration cost	(52,514,758)
Total deferred exploration costs during the year	(51,806,355)	1,586,473
Closing balance		51,806,355
Total exploration and evaluation assets	1	63,115,076
Tuligtic [Member]
IfrsStatementLineItems [Line Items]
Opening balance	11,308,721	11,211,756
Additions		96,965
Deductions
Impairment of acquisition costs	(11,308,720)	0
Closing balance	1	11,308,721
Opening balance	51,806,355	50,219,882
Professional/technical fees	159,031	143,075
Claim maintenance/lease costs		169,651
Geochemical, metallurgy	1,022	3,929
Travel and accommodation	70,324	155,195
Geology, geophysics and exploration	172,455	307,712
Supplies and miscellaneous	318,047	310,804
Environmental and permit	384,421	640,541
Value-added tax (Note 4)	164,189	251,775
Refund - Value-added tax	(561,086)	(396,209)
Impairment of deferred exploration cost	(52,514,758)	0
Total deferred exploration costs during the year	(51,806,355)	1,586,473
Closing balance		51,806,355
Total exploration and evaluation assets	1	63,115,076
Other property, plant and equipment [member]
IfrsStatementLineItems [Line Items]
Opening balance		1
Additions
Deductions		(1)
Impairment of acquisition costs
Closing balance
Opening balance
Professional/technical fees
Claim maintenance/lease costs
Geochemical, metallurgy
Travel and accommodation
Geology, geophysics and exploration
Supplies and miscellaneous
Environmental and permit
Refund - Value-added tax
Impairment of deferred exploration cost
Total deferred exploration costs during the year
Closing balance
Total exploration and evaluation assets

Exploration and evaluation as_4

Exploration and evaluation assets (Details Narrative) - CAD ($)		12 Months Ended
	May 26, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
IfrsStatementLineItems [Line Items]
Impairment of acquisition costs		$ 11,308,720
Impairment of deferred exploration cost		52,514,758
VAT recovery		561,086	$ 396,209	$ 506,394
VAT refund from prior years		173,876	139,313	$ 446,184
Tuligtic [Member]
IfrsStatementLineItems [Line Items]
Impairment of acquisition costs		11,308,720	0
Impairment of deferred exploration cost		$ 52,514,758	$ 0
Logan Property Located In The Yukon Territory Canada [Member]
IfrsStatementLineItems [Line Items]
Proportion of ownership interest in associate	40%
Carrying value of property	$ 1

Gold loan payable and gold in_3

Gold loan payable and gold in trust (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Gold Loan Derivative Instruments [Member]
IfrsStatementLineItems [Line Items]
Derivative financial liabilities, beginning balance	$ 306,084	$ 391,620
Change in fair value through profit & loss	(191,732)	(110,177)
Foreign exchange difference	(5,522)	24,641
Derivative financial liabilities, ending balance	108,830	306,084
Gold Loan [Member]
IfrsStatementLineItems [Line Items]
Gold loan payable, beginning balance	3,929,015	3,227,545
Accrued interest expense	353,372	314,024
Accrued standby fees	10,377	9,416
Accretion expense	176,960	144,868
Foreign exchange difference	(98,178)	233,162
Gold loan payable, ending balance	$ 4,371,546	$ 3,929,015

Gold loan payable and gold in_4

Gold loan payable and gold in trust (Details 1)	12 Months Ended
	Dec. 31, 2023 CAD ($) oz	Dec. 31, 2022 CAD ($) oz	Dec. 31, 2021 CAD ($) oz
IfrsStatementLineItems [Line Items]
Gold in trust, amount	$ 974,397
Change in fair value through profit & loss, amount	132,895	$ (6,518)	$ (35,775)
Gold in trust, amount	$ 1,082,801	$ 974,397
Gold Loan [Member]
IfrsStatementLineItems [Line Items]
Gold in trust, beginning balance, ounces | oz	397	397
Gold in trust, amount	$ 974,397	$ 915,995
Sale of gold in trust, ounces | oz
Sale of gold in trust, amount
Gain on sale, amount
Change in fair value through profit & loss, amount	132,895	(6,518)
Foreign exchange difference, amount	$ (24,491)	$ 64,920
Gold in trust, ending balance, ounces | oz	397	397	397
Gold in trust, amount	$ 1,082,801	$ 974,397	$ 915,995

Gold loan payable and gold in_5

Gold loan payable and gold in trust (Details Narrative)		12 Months Ended
	May 14, 2019 USD ($) Integer shares	Dec. 31, 2023 CAD ($) oz	Dec. 31, 2022 CAD ($) oz	Dec. 31, 2021 CAD ($) oz	May 14, 2019 CAD ($) $ / shares
IfrsStatementLineItems [Line Items]
Borrowings, metals, noncurrent		$ 4,371,546	$ 3,929,015
Net gains (losses) on change in fair value of derivatives		191,732	110,177	$ (18,156)
Trust assets, metals		$ 1,082,801	$ 974,397
Gold Loan Derivative Instruments [Member]
IfrsStatementLineItems [Line Items]
Deriviative liability, assumptions, expected life (Year)	5 years	3 months	1 year 3 months
Derivative liability, assumptions, risk-free interest rate	1.57%	4%	4%
Derivative liability, assumptions, expected volatility	11.06%	9.93%	11.57%
Net gains (losses) on change in fair value of derivatives		$ 191,732	$ 110,177
Warrants [member]
IfrsStatementLineItems [Line Items]
Number of warrants issued (in shares) | shares	500,000
Warrants, exercise price (in CAD per share) | $ / shares					$ 1.50
Warrants, fair value					$ 50,000
Warrants, valuation assumptions, expected life (Year)	5 years
Risk free interest rate, warrants granted	1.54%
Expected dividend, warrants granted	0%
Description of expected volatility warrants granted	44.25%
Gold Loan [Member]
IfrsStatementLineItems [Line Items]
Loan payable, ounces, loaned to company	1,597				1,597
Borrowings, metals, noncurrent	$ 2,072,060				$ 2,790,858
Loan payable, extension period (Year)	2 years
Loan payable, gold delivery payments per month, ounces | Integer	100
Borrowings, interest rate	10%				10%
Borrowings, standby fee	1%				1%
Loans payable, ounces of gold | oz		397	397	397
Trust assets, metals		$ 1,082,801	$ 974,397	$ 915,995

Warrant liability (Details)

Warrant liability (Details) - Warrants [member]	12 Months Ended
	Dec. 31, 2023
IfrsStatementLineItems [Line Items]
Risk free interest rate	0.53%
Expected life of warrants	3 years
Expected annualized volatility	72.42%
Forfeiture rate	0%

Warrant liability (Details 1)

Warrant liability (Details 1) - Derivative Financial Liability [Member]	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Risk free interest rate	3.91%	3.99%
Expected life of warrants (in years)	2 months 15 days	1 year 2 months 15 days
Expected annualized volatility	36.25%	69.83%
Forfeiture rate	0%	0%

Warrant liability (Details Narr

Warrant liability (Details Narrative) - Derivative Financial Liability [Member] - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Warrants exercisable	7,923,077
Warrants exercisable share price	$ 0.80
Fair value of warrants	$ 2,371,174
Change in fair value of derivative financial liability	$ 102,787	$ 520,503

Share capital and reserves (Det

Share capital and reserves (Details)	12 Months Ended
	Dec. 31, 2023 shares $ / shares $ / shares	Dec. 31, 2022 shares $ / shares $ / shares	Dec. 31, 2021 shares $ / shares $ / shares	Dec. 31, 2023 $ / shares	Dec. 31, 2022 $ / shares	Dec. 31, 2021 $ / shares
IfrsStatementLineItems [Line Items]
Balance, outstanding and exercisable	17,448,504	22,168,504	13,809,658
Issued, outstanding and exercisable (in shares)			8,358,846
Exercised, outstanding and exercisable (in shares)
Expired, outstanding and exercisable (in shares)	(8,589,658)	(4,720,000)
Balance, oustanding and exercisable	8,858,846	17,448,504	22,168,504
Balance, weighted average exercise price | $ / shares	$ 0.88	$ 0.95	$ 0.92
Issued, weighted average exercise price | $ / shares			1
Exercised, weighted average exercise price | $ / shares
Expired, weighted average exercise price | $ / shares	0.64	1.35
Balance, weighted average exercise price | $ / shares	$ 1.08	$ 0.88	$ 0.95
Warrants Expiry [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 27, 2023	Mar. 27, 2023	Mar. 27, 2023
Exercise price | $ / shares				$ 0.50	$ 0.50	$ 0.50
Balance	5,489,658	5,489,658	5,489,658
Issued
Exercised
Issued	(5,489,658)
Balance		5,489,658	5,489,658
Warrants Expiry One [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Aug. 06, 2023	Aug. 06, 2023	Aug. 06, 2023
Exercise price | $ / shares				0.90	0.90	0.90
Balance	3,100,000	3,100,000	3,100,000
Issued
Exercised
Issued	(3,100,000)
Balance		3,100,000	3,100,000
Warrants Expiry Two [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 18, 2024	Mar. 18, 2024	Mar. 18, 2024
Exercise price | $ / shares	$ 0.80	$ 0.80	$ 0.80
Balance	7,923,077	7,923,077
Issued			7,923,077
Exercised
Issued
Balance	7,923,077	7,923,077	7,923,077
Warrants Expiry Three [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 18, 2024	Mar. 18, 2024	Mar. 18, 2024
Exercise price | $ / shares	$ 0.80	$ 0.80	$ 0.80
Balance	435,769	435,769
Issued			435,769
Exercised
Issued
Balance	435,769	435,769	435,769
Warrants Expiry Four [Member]
IfrsStatementLineItems [Line Items]
Expiry date	May 14, 2024	May 14, 2024	May 14, 2024
Exercise price | $ / shares				$ 1.50	1.50	1.50
Balance	500,000	500,000	500,000
Issued
Exercised
Issued
Balance	500,000	500,000	500,000
Warrants Expiry Five [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Jun. 07, 2022	Jun. 07, 2022
Exercise price | $ / shares					$ 1.35	$ 1.35
Balance		4,720,000	4,720,000
Issued
Exercised
Issued		(4,720,000)
Balance			4,720,000

Share capital and reserves (D_2

Share capital and reserves (Details 1) - Warrants Issued On March 182021 [Member]	12 Months Ended
	Dec. 31, 2022 shares $ / shares
IfrsStatementLineItems [Line Items]
Number of warrants | shares	435,769
Fair value per share | $ / shares	$ 0.30
Risk free interest rate	0.53%
Expected life (Year)	3 years
Expected volatility	72.42%

Share capital and reserves (D_3

Share capital and reserves (Details 2)	12 Months Ended
	Dec. 31, 2023 shares $ / shares	Dec. 31, 2022 shares $ / shares	Dec. 31, 2021 shares $ / shares
IfrsStatementLineItems [Line Items]
Stock options, balance, outstanding and exercisable (in shares)	12,530,000	11,990,000	11,542,000
Stock options, granted, outstanding and exercisable (in shares)	6,130,000	6,375,000	6,380,000
Stock options, exercised, outstanding and exercisable (in shares)			(725,000)
Options outstanding and exercisable, expired (in shares)	(6,155,000)	(5,835,000)	(5,207,000)
Stock options, balance, outstanding and exercisable (in shares)	12,505,000	12,530,000	11,990,000
Stock options, balance, weighted average exercise price | $ / shares	$ 0.49	$ 0.68	$ 0.80
Weighted average exercise price, granted | $ / shares	0.21	0.34	0.67
Stock options, exercised, weighted average exercise price | $ / shares			0.78
Weighted average exercise price, expired | $ / shares	0.66	0.71	0.90
Stock options, balance, weighted average exercise price | $ / shares	$ 0.27	$ 0.49	$ 0.68
Stock Options Expiry Date February 09, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Feb. 09, 2023	Feb. 09, 2023	Feb. 09, 2023
Stock Options, exercise price | $ / shares	$ 0.97	$ 0.97	$ 0.97
Stock options, balance	350,000	350,000
Stock options, granted			450,000
Stock options, exercised
Stock options, expired	(350,000)		(100,000)
Stock options, balance		350,000	350,000
Stock Options Expiry Date March 3, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 03, 2023	Mar. 03, 2023	Mar. 03, 2023
Stock Options, exercise price | $ / shares	$ 0.96	$ 0.96	$ 0.96
Stock options, balance	250,000	250,000
Stock options, granted			325,000
Stock options, exercised
Stock options, expired	(250,000)		(75,000)
Stock options, balance		250,000	250,000
Stock Options Expiry Date March 31, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2023
Stock Options, exercise price | $ / shares	$ 0.68	$ 0.68	$ 0.68
Stock options, balance	1,975,000	1,975,000
Stock options, granted			1,975,000
Stock options, exercised
Stock options, expired	(1,975,000)
Stock options, balance		1,975,000	1,975,000
Stock Option Expiry Date May 8, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	May 08, 2023	May 08, 2023	May 08, 2023
Stock Options, exercise price | $ / shares	$ 0.69	$ 0.69	$ 0.69
Stock options, balance	100,000	100,000
Stock options, granted			100,000
Stock options, exercised
Stock options, expired	(100,000)
Stock options, balance		100,000	100,000
Stock Option Expiry Date May 28, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	May 28, 2023	May 28, 2023	May 28, 2023
Stock Options, exercise price | $ / shares	$ 0.65	$ 0.65	$ 0.65
Stock options, balance	100,000	100,000
Stock options, granted			100,000
Stock options, exercised
Stock options, expired	(100,000)
Stock options, balance		100,000	100,000
Stock Option Expiry Date July 8, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Jul. 08, 2023	Jul. 08, 2023	Jul. 08, 2023
Stock Options, exercise price | $ / shares	$ 0.62	$ 0.62	$ 0.62
Stock options, balance	2,420,000	2,470,000
Stock options, granted			2,470,000
Stock options, exercised
Stock options, expired	(2,420,000)	(50,000)
Stock options, balance		2,420,000	2,470,000
Stock Options Expiry Date September 18, 2023 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Sep. 18, 2023	Sep. 18, 2023	Sep. 18, 2023
Stock Options, exercise price | $ / shares	$ 0.51	$ 0.51	$ 0.51
Stock options, balance	960,000	960,000
Stock options, granted			960,000
Stock options, exercised
Stock options, expired	(960,000)
Stock options, balance		960,000	960,000
Stock Options Expiry Date March 7, 2027 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Mar. 07, 2027	Mar. 07, 2027
Stock Options, exercise price | $ / shares	$ 0.38	$ 0.38
Stock options, balance	1,125,000
Stock options, granted		1,125,000
Stock options, exercised
Stock options, expired
Stock options, balance	1,125,000	1,125,000
Stock Options Expiry Date June 10, 2027 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Jun. 10, 2027	Jun. 10, 2027
Stock Options, exercise price | $ / shares	$ 0.33	$ 0.33
Stock options, balance	3,640,000
Stock options, granted		3,640,000
Stock options, exercised
Stock options, expired
Stock options, balance	3,640,000	3,640,000
Stock Options Expiry Date October 4, 2027 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Oct. 04, 2027	Oct. 04, 2027
Stock Options, exercise price | $ / shares	$ 0.30	$ 0.30
Stock options, balance	755,000
Stock options, granted		755,000
Stock options, exercised
Stock options, expired
Stock options, balance	755,000	755,000
Stock Options Expiry Date December 16, 2027 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Dec. 16, 2027	Dec. 16, 2027
Stock Options, exercise price | $ / shares	$ 0.33	$ 0.33
Stock options, balance	855,000
Stock options, granted		855,000
Stock options, exercised
Stock options, expired
Stock options, balance	855,000	855,000
Stock Options Expiry Date February 14, 2028 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Feb. 14, 2028
Stock Options, exercise price | $ / shares	$ 0.30
Stock options, balance
Stock options, granted	600,000
Stock options, exercised
Stock options, expired
Stock options, balance	600,000
Stock Options Expiry Date April 3, 2028 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Apr. 03, 2028
Stock Options, exercise price | $ / shares	$ 0.26
Stock options, balance
Stock options, granted	1,975,000
Stock options, exercised
Stock options, expired
Stock options, balance	1,975,000
Stock Options Expiry Date July 10, 2028 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Jul. 10, 2028
Stock Options, exercise price | $ / shares	$ 0.16
Stock options, balance
Stock options, granted	2,520,000
Stock options, exercised
Stock options, expired
Stock options, balance	2,520,000
Stock Options Expiry Date September 19, 2028 [Member]
IfrsStatementLineItems [Line Items]
Expiry date	Sep. 19, 2028
Stock Options, exercise price | $ / shares	$ 0.18
Stock options, balance
Stock options, granted	1,035,000
Stock options, exercised
Stock options, expired
Stock options, balance	1,035,000
Stock Options Expiry Date March 4, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Mar. 04, 2022	Mar. 04, 2022
Stock Options, exercise price | $ / shares		$ 0.47	$ 0.47
Stock options, balance		1,125,000	1,125,000
Stock options, granted
Stock options, exercised
Stock options, expired		(1,125,000)
Stock options, balance			1,125,000
Stock Options Expiry Date April 30, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Apr. 30, 2022	Apr. 30, 2022
Stock Options, exercise price | $ / shares		$ 0.41	$ 0.41
Stock options, balance		100,000	100,000
Stock options, granted
Stock options, exercised
Stock options, expired		(100,000)
Stock options, balance			100,000
Stock Options Expiry Date April 30, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Apr. 30, 2022	Apr. 30, 2022
Stock Options, exercise price | $ / shares		$ 0.58	$ 0.58
Stock options, balance		220,000	220,000
Stock options, granted
Stock options, exercised
Stock options, expired		(220,000)
Stock options, balance			220,000
Stock Options Expiry Date May 31, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		May 31, 2022	May 31, 2022
Stock Options, exercise price | $ / shares		$ 0.62	$ 0.62
Stock options, balance		600,000	700,000
Stock options, granted
Stock options, exercised
Stock options, expired		(600,000)	(100,000)
Stock options, balance			600,000
Stock Options Expiry Date June 9, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Jun. 09, 2022	Jun. 09, 2022
Stock Options, exercise price | $ / shares		$ 0.64	$ 0.64
Stock options, balance		1,980,000	2,180,000
Stock options, granted
Stock options, exercised
Stock options, expired		(1,980,000)	(200,000)
Stock options, balance			1,980,000
Stock Options Expiry Date October 3, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Oct. 03, 2022	Oct. 03, 2022
Stock Options, exercise price | $ / shares		$ 1.13	$ 1.13
Stock options, balance		860,000	1,346,000
Stock options, granted
Stock options, exercised
Stock options, expired		(860,000)	(486,000)
Stock options, balance			860,000
Stock Options Expiry Date December 15, 2022 [Member]
IfrsStatementLineItems [Line Items]
Expiry date		Dec. 15, 2022	Dec. 15, 2022
Stock Options, exercise price | $ / shares		$ 0.89	$ 0.89
Stock options, balance		900,000	972,000
Stock options, granted
Stock options, exercised
Stock options, expired		(900,000)	(72,000)
Stock options, balance			900,000
Stock Options Expiry Date February 7, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Feb. 07, 2021
Stock Options, exercise price | $ / shares			$ 1.11
Stock options, balance			300,000
Stock options, granted
Stock options, exercised
Stock options, expired			(300,000)
Stock options, balance
Stock Options Expiry Date February 7, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Feb. 07, 2021
Stock Options, exercise price | $ / shares			$ 0.84
Stock options, balance			425,000
Stock options, granted
Stock options, exercised			(375,000)
Stock options, expired			(50,000)
Stock options, balance
Stock Options Expiry Date March 29, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Mar. 29, 2021
Stock Options, exercise price | $ / shares			$ 1.08
Stock options, balance			400,000
Stock options, granted
Stock options, exercised
Stock options, expired			(400,000)
Stock options, balance
Stock Options Expiry Date March 29, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Mar. 29, 2021
Stock Options, exercise price | $ / shares			$ 0.90
Stock options, balance			100,000
Stock options, granted
Stock options, exercised
Stock options, expired			(100,000)
Stock options, balance
Stock Options Expiry Date May 6, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			May 06, 2021
Stock Options, exercise price | $ / shares			$ 0.69
Stock options, balance			557,000
Stock options, granted
Stock options, exercised			(275,000)
Stock options, expired			(282,000)
Stock options, balance
Stock Options Expiry Date July 7, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Jul. 07, 2021
Stock Options, exercise price | $ / shares			$ 0.80
Stock options, balance			1,612,000
Stock options, granted
Stock options, exercised			(75,000)
Stock options, expired			(1,537,000)
Stock options, balance
Stock Options Expiry Date August 13, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Aug. 13, 2021
Stock Options, exercise price | $ / shares			$ 1.01
Stock options, balance			150,000
Stock options, granted
Stock options, exercised
Stock options, expired			(150,000)
Stock options, balance
Stock Options Expiry Date September 16, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Sep. 16, 2021
Stock Options, exercise price | $ / shares			$ 0.90
Stock options, balance			1,155,000
Stock options, granted
Stock options, exercised
Stock options, expired			(1,155,000)
Stock options, balance
Stock Options Expiry Date December 12, 2021 [Member]
IfrsStatementLineItems [Line Items]
Expiry date			Dec. 12, 2021
Stock Options, exercise price | $ / shares			$ 1
Stock options, balance			200,000
Stock options, granted
Stock options, exercised
Stock options, expired			(200,000)
Stock options, balance

Share capital and reserves (D_4

Share capital and reserves (Details 3)	12 Months Ended
	Dec. 31, 2023 shares $ / shares
Grant One [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	1,035,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.10
Risk free interest rate, stock options	3.96%
Expected life, stock options	5 years
Expected volatility, stock options	71.15%
Grant Two [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	2,520,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.12
Risk free interest rate, stock options	3.81%
Expected life, stock options	5 years
Expected volatility, stock options	70.98%
Grant Three [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	1,975,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.15
Risk free interest rate, stock options	2.87%
Expected life, stock options	5 years
Expected volatility, stock options	68.52%
Grant Four [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	600,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.18
Risk free interest rate, stock options	3.43%
Expected life, stock options	5 years
Expected volatility, stock options	68.61%
Grant Five [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	855,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.19
Risk free interest rate, stock options	3.07%
Expected life, stock options	5 years
Expected volatility, stock options	66.04%
Grant Six [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	755,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.22
Risk free interest rate, stock options	3.42%
Expected life, stock options	5 years
Expected volatility, stock options	82.02%
Grant Seven [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	3,640,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.22
Risk free interest rate, stock options	3.38%
Expected life, stock options	5 years
Expected volatility, stock options	82.61%
Grant Eight [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	1,125,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.31
Risk free interest rate, stock options	1.65%
Expected life, stock options	5 years
Expected volatility, stock options	85.37%
Grant Nine [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	960,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.23
Risk free interest rate, stock options	0.45%
Expected life, stock options	2 years
Expected volatility, stock options	82.96%
Grant Ten [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	2,470,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.25
Risk free interest rate, stock options	0.45%
Expected life, stock options	2 years
Expected volatility, stock options	84.98%
Grant Eleven [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	100,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.30
Risk free interest rate, stock options	0.32%
Expected life, stock options	2 years
Expected volatility, stock options	86.03%
Grant Twelve [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	100,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.30
Risk free interest rate, stock options	0.33%
Expected life, stock options	2 years
Expected volatility, stock options	86.33%
Grant Thirteen [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	1,975,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.31
Risk free interest rate, stock options	0.22%
Expected life, stock options	2 years
Expected volatility, stock options	85.85%
Grant Fourteen [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	325,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.43
Risk free interest rate, stock options	0.26%
Expected life, stock options	2 years
Expected volatility, stock options	85.48%
Grant Fifteen [Member]
IfrsStatementLineItems [Line Items]
Stock options, granted | shares	450,000
Fair value per share, stock options (in CAD per share) | $ / shares	$ 0.49
Risk free interest rate, stock options	0.19%
Expected life, stock options	2 years
Expected volatility, stock options	84.04%

Share capital and reserves (D_5

Share capital and reserves (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Notes and other explanatory information [abstract]
Weighted average remaining contractual life of outstanding warrants (Year)	2 months 19 days	9 months 18 days	1 year 6 months 3 days	2 years 29 days
Stock options issuance limitations, maximum percentage of allowed issuable options		10%
Stock options issuance limitations, maximum percentage of allowed issuable options for services rendered		2%
Number of shares authorised (in shares)		1,217,141
Stock option limitations, maximum amount of stock options exercisable during a 3 month period		25%
Weighted average remaining contractual life of outstanding share options (Year)	3 years 11 months 15 days	2 years 6 months 10 days	11 months 23 days	1 year 29 days
Expense from share-based payment transactions with employees	$ 810,150	$ 1,478,100	$ 1,870,800

Related party transactions an_3

Related party transactions and balances (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Related Party Transactions And Balances
Professional fees	$ 50,588		$ 60,000		$ 60,000
Salaries and benefits	398,307	[1]	484,435	[2]	450,522	[3]
Share-based payments	702,000		1,212,300		1,551,850
Directors’ fees	140,000		145,000		102,500
Total	$ 1,290,895		$ 1,901,735		$ 2,164,872
[1]As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.[2]As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.[3]As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.

Related party transactions an_4

Related party transactions and balances (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Azucar [Member]
IfrsStatementLineItems [Line Items]
Administrative services fees included in other income	$ 75,853	$ 185,068	$ 412,812
Amounts receivable, related party transactions	7,005	64,006
Almadex [Member]
IfrsStatementLineItems [Line Items]
Administrative services fees included in other income	1,346,494	1,191,360	969,532
Amounts receivable, related party transactions	369,045	117,044
Almadex [Member] | Drill Equipment [Member]
IfrsStatementLineItems [Line Items]
Outstanding commitments made on behalf of entity, related party transactions	0	80,727
Chairmans Daughter [Member]
IfrsStatementLineItems [Line Items]
Related party, salary contracted	$ 45,300	$ 48,800	$ 41,300

Net loss per share (Details Nar

Net loss per share (Details Narrative) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Notes and other explanatory information [abstract]
Profit loss	$ 63,620,232	$ 11,846,560	$ 2,668,254
Weighted average number of ordinary shares outstanding (in shares)	137,221,408	137,221,408	133,842,894

Supplemental cash flow inform_3

Supplemental cash flow information (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Supplemental Cash Flow Information
Exploration and evaluation assets expenditures included in trade and other payables		$ 90,850	$ 89,203
Right-of-use assets			(508,799)
Warrant liability			2,371,174
Fair value of finders’ warrants			130,731
Lease liabilities			508,799
Fair value of cash stock options transferred to share capital on exercise of options			$ 177,250

Supplemental cash flow inform_4

Supplemental cash flow information (Details 1) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Information
Cash	$ 1,658,863	$ 1,542,956
Term Deposits	2,587,120	5,115,120
Total cash and cash equivalents	$ 4,245,983	$ 6,658,076

Income Taxes (Details)

Income Taxes (Details) - CAD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes
Loss before income taxes	$ (66,710,410)	$ (10,505,375)	$ (2,354,113)
Statutory rate	27%	27%	27%
Expected income tax	$ (18,011,811)	$ (2,836,451)	$ (635,611)
Effect of different tax rates in foreign jurisdictions	(2,005,959)	(83,891)	5,281
Non-deductible share-based payments	218,741	399,087	505,116
Other permanent items	2,484,720	1,838,169	(620,413)
Change in deferred tax assets not recognized	15,403,428	2,471,723	733,447
Share issuance costs			(331,660)
True-ups and other	(1,179,327)	(447,452)	657,981
Deferred income tax (recovery) expense	$ (3,090,208)	$ 1,341,185	$ 314,141

Income Taxes (Details 1)

Income Taxes (Details 1) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
Income Taxes
Non-capital losses		$ 2,477,570
Exploration and evaluation assets, deferred tax assets	1,434,880
Deferred tax assets	1,434,880	2,477,570
Exploration and evaluation assets, deferred tax liabilities	(1,434,880)	(5,567,778)
Net deferred tax liabilities		$ (3,090,208)

Income Taxes (Details 2)

Income Taxes (Details 2) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Deductible temporary differences	$ 103,635,630	$ 67,113,271
Noncapital Loss Carry Forwards [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	32,616,394	25,487,951
Capital Loss Carry Forwards [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	23,360,422	24,538,993
Exploration and Evaluation Assets [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	39,102,815	8,188,922
Share Issue Costs [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	551,134	858,548
Property, Plant and Equipment [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	7,748,032	7,782,024
Donations [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	32,960	32,960
Investment Tax Credit [Member]
IfrsStatementLineItems [Line Items]
Deductible temporary differences	$ 223,873	$ 223,873

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
Country Of Canada [Member]
IfrsStatementLineItems [Line Items]
Operating loss carryforwards	$ 27,592,166	$ 25,487,951
Country Of Mexico [Member]
IfrsStatementLineItems [Line Items]
Operating loss carryforwards	$ 4,588,699	$ 0

Financial instruments (Details)

Financial instruments (Details)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 CAD ($)	Dec. 31, 2023 MXN ($)	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 CAD ($)	Dec. 31, 2020 CAD ($)
Notes and other explanatory information [abstract]
Cash and cash equivalents	$ 2,343,681	$ 4,245,983	$ 458,149	$ 6,658,076	$ 10,170,376	$ 2,534,698
Accounts receivable and prepaid expenses	4,703		113
Gold in trust	1,082,801
Total assets	3,431,185		458,262
Trade and other payables	53,348	851,158	14,087	340,509
Gold loan payable	4,371,546
Derivatives financial liabilities	108,830
Total liabilities	4,533,724		14,087	$ 102,787
Net assets	$ (1,102,539)		$ 444,175

Financial instruments (Details

Financial instruments (Details 1) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Derivative financial liabilities	$ 108,830	$ 306,084
Level 1 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Derivative financial liabilities
Level 2 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Derivative financial liabilities	108,830
Level 3 of fair value hierarchy [member]
IfrsStatementLineItems [Line Items]
Derivative financial liabilities

Financial instruments (Detail_2

Financial instruments (Details Narrative)	12 Months Ended
	Dec. 31, 2023 CAD ($)
Notes and other explanatory information [abstract]
Possible effect of 10% change in exchange rate regarding the USD to the net income (loss)	$ 110,000
Possible effect of 10% change in exchange rate regarding the MXN to the net income (loss)	44,000
Possible effect of 1% change in the interest rate to the net income (loss)	42,000
Possible effect of 1% change in the commodity price to the net income (loss)	$ 11,000

Segmented information (Details)

Segmented information (Details) - CAD ($)	Dec. 31, 2023	Dec. 31, 2022
IfrsStatementLineItems [Line Items]
Non-current assets	$ 6,932,340	$ 70,158,266
Country Of Canada [Member]
IfrsStatementLineItems [Line Items]
Non-current assets	361,967	472,435
Country Of United States [Member]
IfrsStatementLineItems [Line Items]
Non-current assets	6,568,840	6,568,840
Country Of Mexico [Member]
IfrsStatementLineItems [Line Items]
Non-current assets	$ 1,533	$ 63,116,991